form_type stringclasses 2 values | accession_number stringlengths 20 20 | filing_date stringdate 2017-03-15 11:31:43 2023-10-30 21:56:06 | quarter_ending stringclasses 448 values | company_name stringlengths 2 58 | text stringlengths 99 9.36k | entities listlengths 1 50 |
|---|---|---|---|---|---|---|
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Separate from the DriveTime Lease Agreement, in December 2016, the Company entered into a lease agreement related to a vehicle inspection and reconditioning center in Tolleson, Arizona, with Verde Investments, Inc., an affiliate of DriveTime ("Verde"), with an initial term of approximately 15 years. The lease agreement requires monthly rental payments and can be extended for four additional five-year periods. In February 2017, the Company also entered into a lease with DriveTime for sole occupancy of a fully-operational inspection and reconditioning center in Winder, Georgia, where the Company previously maintained partial occupancy. The lease has an initial term of eight years, subject to the Company's ability to exercise three renewal options of five years each. | [
{
"Currency / Unit": "cvna:renewal_option",
"End character": 382,
"End date for period": "2016-12-31",
"Label": "cvna:LesseeOperatingLeaseNumberOfRenewalOptions",
"Start character": 378,
"Start date for period": "2016-12-01",
"Value": 4
},
{
"Currency / Unit": "cvna:renewal_option",
"End character": 738,
"End date for period": "2017-02-28",
"Label": "cvna:LesseeOperatingLeaseNumberOfRenewalOptions",
"Start character": 733,
"Start date for period": "2017-02-01",
"Value": 3
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Expenses related to these lease agreements are allocated based on usage to inventory and selling, general and administrative expenses in the accompanying unaudited condensed consolidated balance sheets and statements of operations. Costs allocated to inventory are recognized as cost of sales when the inventory is sold. During the three months ended June 30, 2018, total costs related to these lease agreements were approximately $2.3 million with approximately $1.1 million and $1.2 million allocated to inventory and selling, general and administrative expenses, respectively. During the six months ended June 30, 2018, total costs related to these lease agreements were approximately $4.5 million with approximately $2.1 million and $2.4 million allocated to inventory and selling, general and administrative expenses, respectively. During the three months ended June 30, 2017, total costs related to these lease agreements were approximately $1.8 million with approximately $0.6 million and $1.2 million allocated to inventory and selling, general and administrative expenses, respectively. During the six months ended June 30, 2017, total costs related to these lease agreements were approximately $3.4 million with approximately $1.2 million and $2.2 million allocated to inventory and selling, general and administrative expenses, respectively. | [
{
"Currency / Unit": "USD",
"End character": 435,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 432,
"Start date for period": "2018-04-01",
"Value": 2300000
},
{
"Currency / Unit": "USD",
"End character": 467,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 464,
"Start date for period": "2018-04-01",
"Value": 1100000
},
{
"Currency / Unit": "USD",
"End character": 484,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 481,
"Start date for period": "2018-04-01",
"Value": 1200000
},
{
"Currency / Unit": "USD",
"End character": 692,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 689,
"Start date for period": "2018-01-01",
"Value": 4500000
},
{
"Currency / Unit": "USD",
"End character": 724,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 721,
"Start date for period": "2018-01-01",
"Value": 2100000
},
{
"Currency / Unit": "USD",
"End character": 741,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 738,
"Start date for period": "2018-01-01",
"Value": 2400000
},
{
"Currency / Unit": "USD",
"End character": 951,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 948,
"Start date for period": "2017-04-01",
"Value": 1800000
},
{
"Currency / Unit": "USD",
"End character": 983,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 980,
"Start date for period": "2017-04-01",
"Value": 600000
},
{
"Currency / Unit": "USD",
"End character": 1000,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 997,
"Start date for period": "2018-04-01",
"Value": 1200000
},
{
"Currency / Unit": "USD",
"End character": 1208,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 1205,
"Start date for period": "2017-01-01",
"Value": 3400000
},
{
"Currency / Unit": "USD",
"End character": 1240,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 1237,
"Start date for period": "2018-04-01",
"Value": 1200000
},
{
"Currency / Unit": "USD",
"End character": 1257,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 1254,
"Start date for period": "2017-01-01",
"Value": 2200000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | During the first quarter of 2017, the Company subleased additional office space at DriveTime’s corporate headquarters in Tempe, Arizona. Pursuant to this arrangement, the Company incurred rent expense of approximately $0.1 million during the three months ended March 31, 2017, after which this arrangement was terminated. | [
{
"Currency / Unit": "USD",
"End character": 222,
"End date for period": "2017-03-31",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 219,
"Start date for period": "2017-01-01",
"Value": 100000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In September 2016, the Company entered into a lease with a third party for the second floor of its corporate headquarters in Tempe, Arizona. DriveTime guarantees up to $0.5 million of the Company's rent payments under that lease through September 2019. In connection with that lease, the Company entered into a sublease with DriveTime for the use of the first floor of the same building. The lease and sublease each have a term of 83 months, subject to the right to exercise three five-year extension options. Pursuant to the sublease, which is co-terminus with DriveTime's master lease, the Company will pay DriveTime rent equal to the amounts due under DriveTime's master lease. During the three and six months ended June 30, 2018, the rent expense incurred related to this first floor sublease was approximately $0.2 million and $0.4 million, respectively. During the three and six months ended June 30, 2017, the rent expense incurred related to this first floor sublease was approximately $0.2 million and $0.3 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 172,
"End date for period": "2016-09-30",
"Label": "us-gaap:GuaranteeObligationsMaximumExposure",
"Start character": 169,
"Start date for period": "2016-09-30",
"Value": 500000
},
{
"Currency / Unit": "cvna:renewal_option",
"End character": 480,
"End date for period": "2016-09-30",
"Label": "cvna:LesseeOperatingLeaseNumberOfRenewalOptions",
"Start character": 475,
"Start date for period": "2016-09-01",
"Value": 3
},
{
"Currency / Unit": "USD",
"End character": 819,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 816,
"Start date for period": "2018-04-01",
"Value": 200000
},
{
"Currency / Unit": "USD",
"End character": 836,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 833,
"Start date for period": "2018-01-01",
"Value": 400000
},
{
"Currency / Unit": "USD",
"End character": 998,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 995,
"Start date for period": "2018-04-01",
"Value": 200000
},
{
"Currency / Unit": "USD",
"End character": 1015,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 1012,
"Start date for period": "2017-01-01",
"Value": 300000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In December 2016, the Company entered into a master dealer agreement with DriveTime (the "Master Dealer Agreement"), pursuant to which the Company may sell vehicle service contracts ("VSCs") and GAP waiver coverage to customers purchasing a vehicle from the Company. The Company earns a commission on each VSC sold to its customers and DriveTime is obligated by and subsequently administers the VSCs. The Company collects the retail purchase price of the VSCs from its customers and remits the purchase price net of commission to DriveTime. The Company recognized approximately $5.5 million and $9.7 million during the three and six months ended June 30, 2018, respectively, and approximately $1.9 million and $3.7 million during the three and six months ended June 30, 2017, respectively, of commissions earned on VSCs sold to its customers and administered by DriveTime. The commission earned on the sale of these VSCs is included in other sales and revenues in the accompanying unaudited condensed consolidated statements of operations. | [
{
"Currency / Unit": "USD",
"End character": 582,
"End date for period": "2018-06-30",
"Label": "us-gaap:RevenueFromRelatedParties",
"Start character": 579,
"Start date for period": "2018-04-01",
"Value": 5500000
},
{
"Currency / Unit": "USD",
"End character": 599,
"End date for period": "2018-06-30",
"Label": "us-gaap:RevenueFromRelatedParties",
"Start character": 596,
"Start date for period": "2018-01-01",
"Value": 9700000
},
{
"Currency / Unit": "USD",
"End character": 697,
"End date for period": "2017-06-30",
"Label": "us-gaap:RevenueFromRelatedParties",
"Start character": 694,
"Start date for period": "2017-04-01",
"Value": 1900000
},
{
"Currency / Unit": "USD",
"End character": 714,
"End date for period": "2017-06-30",
"Label": "us-gaap:RevenueFromRelatedParties",
"Start character": 711,
"Start date for period": "2017-01-01",
"Value": 3700000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | DriveTime also administers the Company's GAP waiver coverage under the Master Dealer Agreement. The Company pays a per-contract fee to DriveTime to administer the GAP waiver coverage it sells to its customers. The Company incurred approximately $0.0 million and $0.1 million during the three and six months ended June 30, 2018, respectively, and $0.0 million during the both the three and six months ended June 30, 2017 related to the administration of GAP waiver coverage. | [
{
"Currency / Unit": "USD",
"End character": 249,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 246,
"Start date for period": "2018-04-01",
"Value": 0
},
{
"Currency / Unit": "USD",
"End character": 267,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 264,
"Start date for period": "2018-01-01",
"Value": 100000
},
{
"Currency / Unit": "USD",
"End character": 351,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 348,
"Start date for period": "2018-04-01",
"Value": 0
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | The Company entered into an agreement to share usage of two aircraft operated by DriveTime on October 22, 2015, and the agreement was subsequently amended on May 15, 2017. Pursuant to the agreement, the Company agreed to reimburse DriveTime for actual expenses for each of the flights in which the Company uses the aircrafts. The original agreement was for 12 months, with perpetual 12-month automatic renewals. Either the Company or DriveTime can terminate the agreement with 30 days’ prior written notice. The Company reimbursed DriveTime approximately $0.2 million and $0.3 million, respectively, under this agreement during the three months ended June 30, 2018 and 2017, respectively, and approximately $0.2 million and $0.4 million under this agreement during the six months ended June 30, 2018 and 2017, respectively. | [
{
"Currency / Unit": "cvna:aircraft",
"End character": 59,
"End date for period": "2015-10-22",
"Label": "cvna:NumberOfAircrafts",
"Start character": 56,
"Start date for period": "2015-10-22",
"Value": 2
},
{
"Currency / Unit": "USD",
"End character": 560,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 557,
"Start date for period": "2018-04-01",
"Value": 200000
},
{
"Currency / Unit": "USD",
"End character": 577,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 574,
"Start date for period": "2017-04-01",
"Value": 300000
},
{
"Currency / Unit": "USD",
"End character": 712,
"End date for period": "2018-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 709,
"Start date for period": "2018-04-01",
"Value": 200000
},
{
"Currency / Unit": "USD",
"End character": 729,
"End date for period": "2017-06-30",
"Label": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"Start character": 726,
"Start date for period": "2017-01-01",
"Value": 400000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | On February 27, 2017, the Company entered into a credit facility with Verde for an amount up to $50.0 million (the "Verde Credit Facility"). Amounts outstanding accrued interest at a rate of 12.0% per annum. Upon execution of the agreement, the Company paid Verde a commitment fee of $1.0 million. In connection with the IPO, the Company repaid the outstanding principal balance of $35.0 million and accrued interest of approximately $0.4 million in full and the Verde Credit Facility agreement terminated. | [
{
"Currency / Unit": "USD",
"End character": 101,
"End date for period": "2017-02-27",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 97,
"Start date for period": "2017-02-27",
"Value": 50000000
},
{
"Currency / Unit": "pure",
"End character": 195,
"End date for period": "2017-02-27",
"Label": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
"Start character": 191,
"Start date for period": "2017-02-27",
"Value": 0.12
},
{
"Currency / Unit": "USD",
"End character": 288,
"End date for period": "2017-02-27",
"Label": "us-gaap:DebtInstrumentFeeAmount",
"Start character": 285,
"Start date for period": "2017-02-27",
"Value": 1000000
},
{
"Currency / Unit": "USD",
"End character": 387,
"End date for period": "2017-05-03",
"Label": "us-gaap:RepaymentsOfLongTermLinesOfCredit",
"Start character": 383,
"Start date for period": "2017-05-03",
"Value": 35000000
},
{
"Currency / Unit": "USD",
"End character": 438,
"End date for period": "2017-05-03",
"Label": "cvna:ExtinguishmentOfDebtPaymentOfAccruedInterest",
"Start character": 435,
"Start date for period": "2017-05-03",
"Value": 400000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In December 2016, the Company entered into a master purchase and sale agreement (the "Purchase and Sale Agreement") and a master transfer agreement (the "2016 Master Transfer Agreement") pursuant to which it sells finance receivables meeting certain underwriting criteria to certain third party purchasers, including Ally Bank and Ally Financial (the "Ally Parties"). Through November 2017 under the Purchase and Sale Agreement and the 2016 Master Transfer Agreement, the Company could sell up to an aggregate of $375.0 million, and $292.2 million, respectively, in principal balances of finance receivables subject to adjustment as described in the respective agreements. On November 3, 2017, the Company amended its Purchase and Sale Agreement to increase the aggregate amount of principal balances of finance receivables it can sell from $375.0 million to $1.5 billion. Also on November 3, 2017, the Company terminated the remaining capacity under the 2016 Master Transfer Agreement and replaced this facility by entering into a new master transfer agreement (the "2017 Master Transfer Agreement") with a third party under which the third party has committed to purchase up to an aggregate of approximately $357.1 million in principal balances of finance receivables. | [
{
"Currency / Unit": "USD",
"End character": 519,
"End date for period": "2016-12-31",
"Label": "cvna:TransferofFinancialAssetsAccountedforasSalesMaximumAmountEligibleToBeSold",
"Start character": 514,
"Start date for period": "2016-12-31",
"Value": 375000000
},
{
"Currency / Unit": "USD",
"End character": 539,
"End date for period": "2016-12-31",
"Label": "cvna:TransferofFinancialAssetsAccountedforasSalesMaximumAmountEligibleToBeSold",
"Start character": 534,
"Start date for period": "2016-12-31",
"Value": 292200000
},
{
"Currency / Unit": "USD",
"End character": 847,
"End date for period": "2016-12-31",
"Label": "cvna:TransferofFinancialAssetsAccountedforasSalesMaximumAmountEligibleToBeSold",
"Start character": 842,
"Start date for period": "2016-12-31",
"Value": 375000000
},
{
"Currency / Unit": "USD",
"End character": 863,
"End date for period": "2017-11-03",
"Label": "cvna:TransferofFinancialAssetsAccountedforasSalesMaximumAmountEligibleToBeSold",
"Start character": 860,
"Start date for period": "2017-11-03",
"Value": 1500000000
},
{
"Currency / Unit": "USD",
"End character": 1216,
"End date for period": "2017-11-03",
"Label": "cvna:TransferofFinancialAssetsAccountedforasSalesMaximumAmountEligibleToBeSold",
"Start character": 1211,
"Start date for period": "2017-11-03",
"Value": 357100000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | During the six months ended June 30, 2018, the Company sold approximately $308.8 million in principal balances of finance receivables under the Purchase and Sale Agreement, and approximately $184.4 million in principal balances of finance receivables under the 2017 Master Transfer Agreement. As of June 30, 2018, there was approximately $847.6 million and $140.5 million of unused capacity under the Purchase and Sale Agreement and the 2017 Master Transfer Agreement, respectively. During the six months ended June 30, 2017, the Company sold approximately $157.7 million in principal balances of finance receivables under the Purchase and Sale Agreement, and approximately $66.6 million in principal balances of finance receivables under the 2016 Master Transfer Agreement. | [
{
"Currency / Unit": "USD",
"End character": 80,
"End date for period": "2018-06-30",
"Label": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
"Start character": 75,
"Start date for period": "2018-06-30",
"Value": 308800000
},
{
"Currency / Unit": "USD",
"End character": 197,
"End date for period": "2018-06-30",
"Label": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
"Start character": 192,
"Start date for period": "2018-06-30",
"Value": 184400000
},
{
"Currency / Unit": "USD",
"End character": 344,
"End date for period": "2018-06-30",
"Label": "cvna:TransferofFinancialAssetsAccountedforasSalesRemainingAmountEligibleToBeSold",
"Start character": 339,
"Start date for period": "2018-06-30",
"Value": 847600000
},
{
"Currency / Unit": "USD",
"End character": 363,
"End date for period": "2018-06-30",
"Label": "cvna:TransferofFinancialAssetsAccountedforasSalesRemainingAmountEligibleToBeSold",
"Start character": 358,
"Start date for period": "2018-06-30",
"Value": 140500000
},
{
"Currency / Unit": "USD",
"End character": 563,
"End date for period": "2017-06-30",
"Label": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
"Start character": 558,
"Start date for period": "2017-06-30",
"Value": 157700000
},
{
"Currency / Unit": "USD",
"End character": 679,
"End date for period": "2017-06-30",
"Label": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
"Start character": 675,
"Start date for period": "2017-06-30",
"Value": 66599999.99999999
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | The total gain on loan sales related to finance receivables sold under these agreements was approximately $12.4 million and $22.3 million during the three and six months ended June 30, 2018, respectively, and approximately $5.4 million and $8.4 million during the three and six months ended June 30, 2017, respectively, which is included in other sales and revenues in the accompanying unaudited condensed consolidated statements of operations. | [
{
"Currency / Unit": "USD",
"End character": 111,
"End date for period": "2018-06-30",
"Label": "us-gaap:SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale",
"Start character": 107,
"Start date for period": "2018-04-01",
"Value": 12400000
},
{
"Currency / Unit": "USD",
"End character": 129,
"End date for period": "2018-06-30",
"Label": "us-gaap:SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale",
"Start character": 125,
"Start date for period": "2018-01-01",
"Value": 22300000
},
{
"Currency / Unit": "USD",
"End character": 227,
"End date for period": "2017-06-30",
"Label": "us-gaap:SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale",
"Start character": 224,
"Start date for period": "2017-04-01",
"Value": 5400000
},
{
"Currency / Unit": "USD",
"End character": 244,
"End date for period": "2017-06-30",
"Label": "us-gaap:SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale",
"Start character": 241,
"Start date for period": "2017-01-01",
"Value": 8400000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | The Company has a floor plan facility with a third party to finance its used vehicle inventory, which is secured by substantially all of its assets, other than the Company's interests in real property (the "Floor Plan Facility"). The Company most recently amended the Floor Plan Facility in August 2017 to, among other things, extend the maturity date to December 31, 2018, and increase the available credit to $275.0 million through December 31, 2017 and to $350.0 million from January 1, 2018 through December 31, 2018. The Company is required to make monthly interest payments at a rate per annum equal to one-month LIBOR plus 3.65%, effective August 1, 2017. The Floor Plan Facility requires that at least 5% of the total principal amount owed to the lender is held as restricted cash. | [
{
"Currency / Unit": "USD",
"End character": 417,
"End date for period": "2017-12-31",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 412,
"Start date for period": "2017-12-31",
"Value": 275000000
},
{
"Currency / Unit": "USD",
"End character": 465,
"End date for period": "2018-01-01",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 460,
"Start date for period": "2018-01-01",
"Value": 350000000
},
{
"Currency / Unit": "pure",
"End character": 634,
"End date for period": "2018-06-30",
"Label": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
"Start character": 630,
"Start date for period": "2018-01-01",
"Value": 0.036500000000000005
},
{
"Currency / Unit": "pure",
"End character": 711,
"End date for period": "2018-06-30",
"Label": "cvna:DebtInstrumentCashDepositRequiredPercentageofPrincipalBalance",
"Start character": 710,
"Start date for period": "2018-06-30",
"Value": 0.05
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Repayment in an amount equal to the amount of the advance or loan must be made within five business days of selling or otherwise disposing of the underlying vehicle inventory, unless customers financed the purchase by originating an automotive finance receivable. For used vehicle sales involving financing originated by the Company and sold under either the Purchase and Sale Agreement or the 2017 Master Transfer Agreement as mentioned in Note 7 — Finance Receivable Sale Agreements, the lender has extended repayment to the earlier of fifteen business days after the sale of the used vehicle or one day following the sale of the related finance receivable. In November 2017, the Company also entered into a letter agreement to extend repayment of amounts due under the Floor Plan Facility for used vehicle sales involving financing that are not sold under either the Purchase and Sale Agreement or the 2017 Master Transfer Agreement. With respect to such vehicles, the lender agreed to extend repayment of the advance or the loan for such vehicles to the earlier of fifteen business days after the sale of the vehicle or two business days following the funding of the related finance receivable. Outstanding balances related to vehicles held in inventory for more than 180 days require monthly principal payments equal to 10% of the original principal amount of that vehicle until the remaining outstanding balance is the lesser of (i) 50% of the original principal amount or (ii) 50% of the wholesale value. Prepayments may be made without incurring a premium or penalty. Additionally, the Company is permitted to make prepayments to the lender to be held as principal payments under the Floor Plan Facility and subsequently re-borrow such amounts. | [
{
"Currency / Unit": "pure",
"End character": 1327,
"End date for period": "2018-06-30",
"Label": "cvna:DebtInstrumentPeriodicPaymentRequiredForInventoryExceedingThresholdOfDaysInInventoryPercentage",
"Start character": 1325,
"Start date for period": "2018-06-30",
"Value": 0.1
},
{
"Currency / Unit": "pure",
"End character": 1441,
"End date for period": "2018-06-30",
"Label": "cvna:DebtInstrumentOutstandingBalanceAsAPercentageOfOriginalPrincipalAmountThresholdWhereMonthlyPaymentsAreNoLongerRequired",
"Start character": 1439,
"Start date for period": "2018-06-30",
"Value": 0.5
},
{
"Currency / Unit": "pure",
"End character": 1486,
"End date for period": "2018-06-30",
"Label": "cvna:DebtInstrumentOutstandingBalanceAsAPercentageOfOriginalPrincipalAmountThresholdWhereMonthlyPaymentsAreNoLongerRequired",
"Start character": 1484,
"Start date for period": "2018-06-30",
"Value": 0.5
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As of June 30, 2018, the interest rate on the Floor Plan Facility was approximately 5.74%, the Company had an outstanding balance under this facility of approximately $347.1 million, borrowing capacity available of approximately $2.9 million and held approximately $17.4 million in restricted cash related to this facility. As of December 31, 2017, the Company held approximately $12.4 million in restricted cash related to this facility. | [
{
"Currency / Unit": "pure",
"End character": 88,
"End date for period": "2018-06-30",
"Label": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
"Start character": 84,
"Start date for period": "2018-06-30",
"Value": 0.0574
},
{
"Currency / Unit": "USD",
"End character": 173,
"End date for period": "2018-06-30",
"Label": "us-gaap:LinesOfCreditCurrent",
"Start character": 168,
"Start date for period": "2018-06-30",
"Value": 347100000
},
{
"Currency / Unit": "USD",
"End character": 233,
"End date for period": "2018-06-30",
"Label": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
"Start character": 230,
"Start date for period": "2018-06-30",
"Value": 2900000
},
{
"Currency / Unit": "USD",
"End character": 270,
"End date for period": "2018-06-30",
"Label": "us-gaap:RestrictedCashCurrent",
"Start character": 266,
"Start date for period": "2018-06-30",
"Value": 17400000
},
{
"Currency / Unit": "USD",
"End character": 385,
"End date for period": "2017-12-31",
"Label": "us-gaap:RestrictedCashCurrent",
"Start character": 381,
"Start date for period": "2017-12-31",
"Value": 12400000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | The Company has entered into promissory note and disbursement agreements to finance certain equipment for its transportation fleet and building improvements. The assets financed with the proceeds from these notes serve as the collateral for each note and certain security agreements related to these assets have cross collateralization and cross default provisions with respect to one another. Each note has a fixed annual interest rate, a two to five-year term and requires monthly payments. As of June 30, 2018, the outstanding principal of these notes had a weighted-average interest rate of 5.6% and totaled approximately $31.3 million, of which approximately $6.7 million is due within the next twelve months and is included as current portion of long-term debt in the accompanying unaudited condensed consolidated balance sheets. | [
{
"Currency / Unit": "pure",
"End character": 598,
"End date for period": "2018-06-30",
"Label": "us-gaap:DebtWeightedAverageInterestRate",
"Start character": 595,
"Start date for period": "2018-06-30",
"Value": 0.056
},
{
"Currency / Unit": "USD",
"End character": 631,
"End date for period": "2018-06-30",
"Label": "us-gaap:NotesPayable",
"Start character": 627,
"Start date for period": "2018-06-30",
"Value": 31300000
},
{
"Currency / Unit": "USD",
"End character": 668,
"End date for period": "2018-06-30",
"Label": "us-gaap:NotesPayableCurrent",
"Start character": 665,
"Start date for period": "2018-06-30",
"Value": 6700000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Beginning in 2017, the Company has financed certain purchases and construction of its property and equipment through various sale and leaseback transactions. As of June 30, 2018, none of these transactions have qualified for sale accounting due to forms of continuing involvement, such as repurchase options or renewal periods that extend the lease for substantially all of the asset's remaining useful life, and are therefore accounted for as financing transactions. These arrangements require monthly payments and have initial terms that expire in fifteen to twenty years. Some of the agreements are subject to renewal options of up to twenty years and base rent increases throughout the term. As of June 30, 2018, the outstanding liability associated with these sale and leaseback arrangements, net of debt issuance costs, is approximately $52.3 million and is included in long-term debt in the accompanying unaudited condensed consolidated balance sheet. | [
{
"Currency / Unit": "USD",
"End character": 848,
"End date for period": "2018-06-30",
"Label": "us-gaap:SaleLeasebackTransactionAmountDueUnderFinancingArrangement",
"Start character": 844,
"Start date for period": "2018-06-30",
"Value": 52300000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In November 2017, the Company entered into a master sale-leaseback agreement (the "MSLA") pursuant to which it may sell and lease back certain of its owned or leased properties and construction improvements. A portion of the Company's finance leases described above is through the MSLA. A portion of the fixed rental payments set forth in the respective lease agreements is payable annually beginning in November 2019. Under the MSLA, at any time the Company may elect to, and beginning in November 2019 or until a property owner of a leased site consents to the sale-leaseback, the purchaser has the right to, demand that the Company repurchase one or more of the properties sold and leased back pursuant to the MSLA for an amount equal to the repurchase price. Repurchase prices are defined in each of the applicable leases and are generally the original purchase prices plus any accrued and unpaid rent. As of June 30, 2018, the repurchase prices for all properties under the MSLA excluding unpaid rent totaled approximately $28.8 million. Under the MSLA, the total sales price of properties the Company has sold and is leasing back at any point in time is limited to $75.0 million. As of June 30, 2018, the Company may sell and lease back an additional approximately $46.2 million of its property and equipment under the MSLA. | [
{
"Currency / Unit": "cvna:property",
"End character": 650,
"End date for period": "2017-11-30",
"Label": "cvna:SaleLeasebackTransactionLeaseTermsNumberOfPropertiesSoldAndLeasedBackAtAmountEqualToTheRepurchasePrice",
"Start character": 647,
"Start date for period": "2017-11-01",
"Value": 1
},
{
"Currency / Unit": "USD",
"End character": 1034,
"End date for period": "2018-06-30",
"Label": "cvna:SaleLeasebackTransactionRepurchasePriceExcludingUnpaidRentTotal",
"Start character": 1030,
"Start date for period": "2018-06-30",
"Value": 28800000
},
{
"Currency / Unit": "USD",
"End character": 1177,
"End date for period": "2017-11-30",
"Label": "cvna:SaleLeasebackTransactionMaximumSalesPriceOfPropertiesSoldAndLeasingBack",
"Start character": 1173,
"Start date for period": "2017-11-30",
"Value": 75000000
},
{
"Currency / Unit": "USD",
"End character": 1277,
"End date for period": "2018-06-30",
"Label": "cvna:SaleLeasebackTransactionAdditionalAmountCompanyMaySellAndLeaseBack",
"Start character": 1273,
"Start date for period": "2018-06-30",
"Value": 46200000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As described in Note 1 — Business Organization, Carvana Group amended and restated its LLC Agreement to, among other things, provide for two classes of common ownership interests in Carvana Group. Carvana Group’s two classes of common ownership interests are Class A Units and Class B Units. Carvana Co. is required to, at all times, maintain (i) a four-to-five ratio between the number of shares of Class A common stock issued and outstanding by Carvana Co. and the number of Class A Units owned by Carvana Co. (subject to certain exceptions for treasury shares and shares underlying certain convertible or exchangeable securities and subject to adjustment as set forth in the exchange agreement (the "Exchange Agreement") further discussed below, and taking into account Carvana Sub’s 0.1% ownership interest in Carvana, LLC) and (ii) a four-to-five ratio between the number of shares of Class B common stock owned by the Original LLC Unitholders and the number of Class A Units owned by the Original LLC Unitholders. The Company may issue shares of Class B common stock only to the extent necessary to maintain these ratios. Shares of Class B common stock are transferable only together with a corresponding number of LLC Units if Carvana Co., at the election of an Existing LLC Unitholder, exchanges LLC Units for shares of Class A common stock. | [
{
"Currency / Unit": "pure",
"End character": 791,
"End date for period": "2017-05-02",
"Label": "cvna:CommonStockPercentageofVotingPower",
"Start character": 788,
"Start date for period": "2017-05-02",
"Value": 0.001
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As of June 30, 2018, there were approximately 175.6 million and 6.0 million Class A Units and Class B Units (as adjusted for the participation thresholds), respectively, issued and outstanding. As discussed in Note 11 — Equity-Based Compensation, Class B Units were issued under the Company’s LLC Equity Incentive Plan (the “LLC Equity Incentive Plan”) and are subject to a participation threshold and are earned over the requisite service period. | [
{
"Currency / Unit": "shares",
"End character": 51,
"End date for period": "2018-06-30",
"Label": "us-gaap:CommonUnitOutstanding",
"Start character": 46,
"Start date for period": "2018-06-30",
"Value": 175600000
},
{
"Currency / Unit": "shares",
"End character": 67,
"End date for period": "2018-06-30",
"Label": "us-gaap:CommonUnitOutstanding",
"Start character": 64,
"Start date for period": "2018-06-30",
"Value": 6000000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | The Selling Stockholder and the Selling LLC Unitholders sold a total of approximately 6.1 million shares of Class A common stock as part of the offering. The Selling LLC Unitholders exchanged approximately 6.9 million LLC Units for approximately 5.6 million shares of Class A common stock to be sold in the offering, and to the extent such Selling LLC | [
{
"Currency / Unit": "shares",
"End character": 89,
"End date for period": "2018-04-30",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 86,
"Start date for period": "2018-04-30",
"Value": 6100000
},
{
"Currency / Unit": "shares",
"End character": 209,
"End date for period": "2018-04-30",
"Label": "us-gaap:ConversionOfStockSharesConverted1",
"Start character": 206,
"Start date for period": "2018-04-30",
"Value": 6900000
},
{
"Currency / Unit": "shares",
"End character": 249,
"End date for period": "2018-04-30",
"Label": "us-gaap:ConversionOfStockSharesIssued1",
"Start character": 246,
"Start date for period": "2018-04-30",
"Value": 5600000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Unitholder held Class B common stock, the corresponding shares of Class B common stock were immediately retired by the Company. The Company did not receive any proceeds from the sale of the approximately 6.1 million shares of Class A common stock by the Selling Stockholder and the Selling LLC Unitholders. | [
{
"Currency / Unit": "USD",
"End character": 146,
"End date for period": "2018-04-30",
"Label": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
"Start character": 144,
"Start date for period": "2018-04-30",
"Value": 0
},
{
"Currency / Unit": "shares",
"End character": 207,
"End date for period": "2018-04-30",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 204,
"Start date for period": "2018-04-30",
"Value": 6100000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | During the six months ended June 30, 2018, certain LLC Unitholders exchanged approximately 12.0 million LLC Units and approximately 8.8 million shares of Class B common stock for approximately 9.6 million newly-issued shares of Class A common stock. Simultaneously, and in connection with these exchanges, Carvana Co. received approximately 12.0 million LLC Units, increasing its total ownership interest in Carvana Group, and canceled the exchanged shares of Class B common stock. | [
{
"Currency / Unit": "shares",
"End character": 95,
"End date for period": "2018-06-30",
"Label": "us-gaap:ConversionOfStockSharesConverted1",
"Start character": 91,
"Start date for period": "2018-01-01",
"Value": 12000000
},
{
"Currency / Unit": "shares",
"End character": 135,
"End date for period": "2018-06-30",
"Label": "us-gaap:ConversionOfStockSharesConverted1",
"Start character": 132,
"Start date for period": "2018-01-01",
"Value": 8800000
},
{
"Currency / Unit": "shares",
"End character": 196,
"End date for period": "2018-06-30",
"Label": "us-gaap:ConversionOfStockSharesIssued1",
"Start character": 193,
"Start date for period": "2018-01-01",
"Value": 9600000
},
{
"Currency / Unit": "shares",
"End character": 345,
"End date for period": "2018-06-30",
"Label": "us-gaap:ConversionOfStockSharesConverted1",
"Start character": 341,
"Start date for period": "2018-01-01",
"Value": 12000000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Upon a change of control, as defined in the agreement, any holder of Convertible Preferred Stock has the option to require the Company (or its successor) to purchase, any or all of its Convertible Preferred Stock at a purchase price per share, payable at the Company’s option in any combination of cash or shares of Class A common stock, of 101% of the liquidation preference, plus all accumulated dividends. | [
{
"Currency / Unit": "pure",
"End character": 344,
"End date for period": "2018-06-30",
"Label": "cvna:PreferredStockChangeofControlRedemption",
"Start character": 341,
"Start date for period": "2018-06-30",
"Value": 1.01
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Upon the issuance of shares of Class A common stock by Carvana Co. related to the Company’s equity compensation plans such as the exercise of options, issuance of restricted or non-restricted stock, payment of bonuses in stock or settlement of stock appreciation rights in stock, Carvana Group is required to issue to Carvana Co. a number of Class A Units equal to 1.25 times the number of shares of Class A common stock being issued in connection with the exercise of such options or issuance of other types of equity compensation, subject to adjustment for stock splits, stock dividends, reclassifications and similar transactions. Activity related to the Company's equity compensation plans may result in a change in ownership which will impact the amount recorded as non-controlling interest and additional paid-in capital. | [
{
"Currency / Unit": "pure",
"End character": 370,
"End date for period": "2018-06-30",
"Label": "cvna:CommonStockConversionRatio",
"Start character": 366,
"Start date for period": "2018-01-01",
"Value": 1.25
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | During the six months ended June 30, 2018, the total adjustments related to exchanges of LLC Units was a decrease in non-controlling interests and a corresponding increase in additional paid-in capital of approximately $12.6 million, which has been included in exchanges of LLC Units in the accompanying unaudited condensed consolidated statement of stockholders' equity. During the six months ended June 30, 2018, Carvana Co. utilized its net proceeds from its follow-on offering to purchase LLC Units, which together with the follow-on offering resulted in an adjustment to increase non-controlling interests and to decrease additional paid-in capital by approximately $132.4 million, which has been included in adjustment to non-controlling interests related to follow-on offering in the accompanying unaudited condensed consolidated statement of stockholders' equity. During | [
{
"Currency / Unit": "USD",
"End character": 678,
"End date for period": "2018-06-30",
"Label": "us-gaap:MinorityInterestDecreaseFromRedemptions",
"Start character": 673,
"Start date for period": "2018-01-01",
"Value": -132400000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As of June 30, 2018, Carvana Co. owned approximately 23.4% of Carvana Group with the LLC Unitholders owning the remaining 76.6%. The non-controlling interests on the accompanying unaudited condensed consolidated statements of operations represents the portion of the loss attributable to the economic interest in Carvana Group held by the non-controlling LLC Unitholders calculated based on the weighted average non-controlling interests' ownership during the periods presented. | [
{
"Currency / Unit": "pure",
"End character": 57,
"End date for period": "2018-06-30",
"Label": "us-gaap:MinorityInterestOwnershipPercentageByParent",
"Start character": 53,
"Start date for period": "2018-06-30",
"Value": 0.234
},
{
"Currency / Unit": "pure",
"End character": 126,
"End date for period": "2018-06-30",
"Label": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
"Start character": 122,
"Start date for period": "2018-06-30",
"Value": 0.766
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As of June 30, 2018, the total unrecognized compensation expense related to outstanding equity awards was approximately $27.8 million, which the Company expects to recognize over a weighted-average period of approximately 3.0 years. Total unrecognized equity-based compensation expense will be adjusted for actual forfeitures. | [
{
"Currency / Unit": "USD",
"End character": 125,
"End date for period": "2018-06-30",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 121,
"Start date for period": "2018-06-30",
"Value": 27800000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In connection with the IPO, the Company adopted the 2017 Omnibus Incentive Plan (the "2017 Incentive Plan"). Under the 2017 Incentive Plan, 14.0 million shares of Class A common stock are available for issuance, which the Company may grant as stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards to employees, directors, officers and consultants. As of June 30, 2018, approximately 12.5 million shares remain available for future equity award grants under this plan. | [
{
"Currency / Unit": "shares",
"End character": 144,
"End date for period": "2018-06-30",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
"Start character": 140,
"Start date for period": "2018-06-30",
"Value": 14000000
},
{
"Currency / Unit": "shares",
"End character": 445,
"End date for period": "2018-06-30",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
"Start character": 441,
"Start date for period": "2018-06-30",
"Value": 12500000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As discussed in Note 1 — Business Organization, the Organizational Transactions are considered transactions between entities under common control and the financial statements for periods prior to the IPO and Organizational Transactions have been adjusted to combine the previously separate entities for presentation purposes. For purposes of calculating both the numerator and denominator of net loss per share for periods prior to the IPO, the Company has retroactively reflected the 15.0 million shares issued in the IPO and the LLC Units outstanding as of the Organizational Transactions as if they had been issued and outstanding as of the beginning of each period presented. These calculations for periods prior to the IPO do not consider the options or shares of Class A common stock issued on the IPO date under the 2017 Incentive Plan. | [
{
"Currency / Unit": "shares",
"End character": 489,
"End date for period": "2017-05-03",
"Label": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
"Start character": 485,
"Start date for period": "2017-05-03",
"Value": 15000000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Weighted-average as-converted shares of Convertible Preferred Stock of approximately 5.1 million for each of the three and six months ended June 30, 2018 were evaluated under the if-converted method for potentially dilutive effects and were determined to be anti-dilutive. Weighted-average as-converted Class A Units together with the related Class B common stock of approximately 110.2 million and 117.2 million during the three months ended June 30, 2018 and June 30, 2017, respectively, and of approximately 112.1 million and 117.2 million during the six months ended June 30, 2018 and June 30, 2017, respectively, were evaluated under the if-converted method for potentially dilutive effects and were determined to be anti-dilutive. Outstanding Class B Units of approximately 6.6 million and 7.5 million at June 30, 2018 and June 30, 2017, respectively, were evaluated for potentially dilutive effects and were determined to be anti-dilutive. Potentially dilutive restricted stock awards and units of approximately 0.4 million and for each of the three and six months ended June 30, 2018 and of approximately 0.2 million and 0.1 million for the three and six months ended June 30, 2017, respectively, were evaluated under the treasury stock method for potentially dilutive effects and were determined to be anti-dilutive. As of June 30, 2018, 0.8 million options were outstanding and evaluated under the treasury stock method for potentially dilutive effects and were determined to be anti-dilutive. During the three and six months ended June 30, 2017, the exercise price of all outstanding options exceeded the average share price of Class A common stock, thus, options were not contemplated in diluted net loss per share computations. | [
{
"Currency / Unit": "shares",
"End character": 386,
"End date for period": "2018-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 381,
"Start date for period": "2018-04-01",
"Value": 110200000
},
{
"Currency / Unit": "shares",
"End character": 404,
"End date for period": "2017-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 399,
"Start date for period": "2017-04-01",
"Value": 117200000
},
{
"Currency / Unit": "shares",
"End character": 516,
"End date for period": "2018-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 511,
"Start date for period": "2018-01-01",
"Value": 112100000
},
{
"Currency / Unit": "shares",
"End character": 534,
"End date for period": "2017-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 529,
"Start date for period": "2017-04-01",
"Value": 117200000
},
{
"Currency / Unit": "shares",
"End character": 784,
"End date for period": "2018-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 781,
"Start date for period": "2018-01-01",
"Value": 6600000
},
{
"Currency / Unit": "shares",
"End character": 800,
"End date for period": "2017-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 797,
"Start date for period": "2017-01-01",
"Value": 7500000
},
{
"Currency / Unit": "shares",
"End character": 1118,
"End date for period": "2017-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 1115,
"Start date for period": "2017-04-01",
"Value": 200000
},
{
"Currency / Unit": "shares",
"End character": 1134,
"End date for period": "2017-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 1131,
"Start date for period": "2017-01-01",
"Value": 100000
},
{
"Currency / Unit": "shares",
"End character": 1352,
"End date for period": "2018-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 1349,
"Start date for period": "2018-01-01",
"Value": 800000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As described in Note 9 — Stockholders' Equity, the Company acquired approximately 12.0 million LLC Units during the six months ended June 30, 2018 in connection with exchanges with Existing LLC Unitholders. During the six months ended June 30, 2018, the Company recorded a gross deferred tax asset of approximately $68.7 million associated with the basis difference in its investment in Carvana Group related to the acquisition of these LLC Units which is reflected as an increase to additional paid-in capital in the accompanying unaudited condensed consolidated statement of stockholders' equity. | [
{
"Currency / Unit": "shares",
"End character": 86,
"End date for period": "2018-06-30",
"Label": "us-gaap:ConversionOfStockSharesConverted1",
"Start character": 82,
"Start date for period": "2018-01-01",
"Value": 12000000
},
{
"Currency / Unit": "USD",
"End character": 320,
"End date for period": "2018-06-30",
"Label": "cvna:DeferredTaxAssetsBasisDifferenceInAcquiredUnits",
"Start character": 316,
"Start date for period": "2018-06-30",
"Value": 68700000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As described in Note 1 — Business Organization and Note 9 — Stockholders' Equity, Carvana Co. purchased approximately 8.3 million newly-issued LLC Units of Carvana Group in connection with the follow-on offering. The Company recognized a gross deferred tax asset of approximately $2.5 million associated with a portion of the basis difference resulting from this purchase of LLC Units which is reflected as an increase to additional paid-in capital in the accompanying unaudited condensed consolidated statements of stockholders' equity. | [
{
"Currency / Unit": "shares",
"End character": 121,
"End date for period": "2018-04-30",
"Label": "us-gaap:InvestmentOwnedBalanceShares",
"Start character": 118,
"Start date for period": "2018-04-30",
"Value": 8300000.000000001
},
{
"Currency / Unit": "USD",
"End character": 284,
"End date for period": "2018-06-30",
"Label": "cvna:DeferredTaxAssetsBasisDifferenceInAcquiredUnits",
"Start character": 281,
"Start date for period": "2018-06-30",
"Value": 2500000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As of June 30, 2018, the Company has concluded based on applicable accounting standards, that it was more likely than not that its deferred tax assets subject to the TRA would not be realized; therefore, the Company has not recorded a liability related to the tax savings it may realize from utilization of such deferred tax assets. As of June 30, 2018, the total unrecorded TRA liability is approximately $67.9 million. If utilization of the deferred tax assets subject to the TRA becomes more likely than not in the future, the Company will record a liability related to the TRA which will be recognized as expense within its consolidated statements of operations. | [
{
"Currency / Unit": "USD",
"End character": 411,
"End date for period": "2018-06-30",
"Label": "cvna:DeferredTaxLiabilityNotRecognizedTaxReceivableAgreement",
"Start character": 407,
"Start date for period": "2018-06-30",
"Value": 67900000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As of June 30, 2018, the Company is a tenant under various operating leases with third parties related to certain of its market hubs, vending machines and offices. The initial terms expire at various dates between 2018 and 2027. Many of the leases include one or more renewal options ranging from two to twenty years. Rent is recognized on a straight-line basis over the lease term and includes scheduled rent increases as well as amortization of tenant improvement allowances. Rent expense for these operating leases was approximately $1.3 million and $2.6 million for the three and six months ended June 30, 2018 and $1.2 million and $1.8 million for the three and six months ended June 30, 2017, respectively. | [
{
"Currency / Unit": "cvna:renewal_option",
"End character": 259,
"End date for period": "2018-06-30",
"Label": "cvna:LesseeOperatingLeaseNumberOfRenewalOptions",
"Start character": 256,
"Start date for period": "2018-01-01",
"Value": 1
},
{
"Currency / Unit": "USD",
"End character": 540,
"End date for period": "2018-06-30",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 537,
"Start date for period": "2018-04-01",
"Value": 1300000
},
{
"Currency / Unit": "USD",
"End character": 557,
"End date for period": "2018-06-30",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 554,
"Start date for period": "2018-01-01",
"Value": 2600000
},
{
"Currency / Unit": "USD",
"End character": 623,
"End date for period": "2017-06-30",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 620,
"Start date for period": "2017-04-01",
"Value": 1200000
},
{
"Currency / Unit": "USD",
"End character": 640,
"End date for period": "2017-06-30",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 637,
"Start date for period": "2017-01-01",
"Value": 1800000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | Beginning in December 2017, the Company has operating leases with third parties for certain of its transportation fleet. The initial lease terms are for two years from the delivery date of each individual vehicle to the Company, at which time each lease will extend on a month-to-month basis for a potential total lease term of six years unless both parties agree to earlier termination or replacement. Rent expense for these operating leases was approximately $0.4 million and $0.7 million for the three and six months ended June 30, 2018, respectively. | [
{
"Currency / Unit": "USD",
"End character": 465,
"End date for period": "2018-06-30",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 462,
"Start date for period": "2018-04-01",
"Value": 400000
},
{
"Currency / Unit": "USD",
"End character": 482,
"End date for period": "2018-06-30",
"Label": "us-gaap:OperatingLeasesRentExpenseNet",
"Start character": 479,
"Start date for period": "2018-01-01",
"Value": 700000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | As part of its retail strategy, the Company provides a 100-day or 4,189-mile limited warranty to customers to repair certain broken or defective components of each used vehicle sold. As such, the Company accrues for such repairs based on actual claims incurred to-date and repair reserves based on historical trends. The liability was approximately $1.0 million and $0.8 million as of June 30, 2018 and December 31, 2017, respectively, and is included in accounts payable and other accrued liabilities in the accompanying unaudited condensed consolidated balance sheets. | [
{
"Currency / Unit": "utr:mi",
"End character": 71,
"End date for period": "2018-06-30",
"Label": "cvna:StandardProductWarrantyNumberOfMiles",
"Start character": 66,
"Start date for period": "2018-01-01",
"Value": 4189
},
{
"Currency / Unit": "USD",
"End character": 353,
"End date for period": "2018-06-30",
"Label": "us-gaap:StandardProductWarrantyAccrual",
"Start character": 350,
"Start date for period": "2018-06-30",
"Value": 1000000
},
{
"Currency / Unit": "USD",
"End character": 370,
"End date for period": "2017-12-31",
"Label": "us-gaap:StandardProductWarrantyAccrual",
"Start character": 367,
"Start date for period": "2017-12-31",
"Value": 800000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | In October 2016, the Company obtained an unconditional, irrevocable, stand-by letter of credit for $1.9 million to satisfy a condition of a new lease agreement. The Company was required to maintain a cash deposit of $1.9 million with the financial institution that issued the stand-by letter of credit until February 2018, at which point the cash deposit requirement was reduced by approximately $1.0 million until November 30, 2018, at which time the letter of credit shall expire. The Company has earned interest on this letter of credit, and as of June 30, 2018 and December 31, 2017, the balance with the financial institution | [
{
"Currency / Unit": "USD",
"End character": 103,
"End date for period": "2016-10-31",
"Label": "us-gaap:LettersOfCreditOutstandingAmount",
"Start character": 100,
"Start date for period": "2016-10-31",
"Value": 1900000
},
{
"Currency / Unit": "USD",
"End character": 220,
"End date for period": "2016-10-31",
"Label": "us-gaap:LettersOfCreditOutstandingAmount",
"Start character": 217,
"Start date for period": "2016-10-31",
"Value": 1900000
},
{
"Currency / Unit": "USD",
"End character": 400,
"End date for period": "2018-02-28",
"Label": "cvna:DepositswithClearingOrganizationsandOthersSecuritiesRequirementDecrease",
"Start character": 397,
"Start date for period": "2018-02-01",
"Value": 1000000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | On August 7, 2018, the Company purchased finance receivables that it previously sold to an unrelated party under the 2017 Master Transfer Agreement for a price of approximately $253.0 million and immediately resold such finance receivables to an unrelated party for the same price under a new transfer agreement. The Company received a fee of approximately $4.0 million for arranging and participating in the transaction. | [
{
"Currency / Unit": "USD",
"End character": 183,
"End date for period": "2018-08-07",
"Label": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
"Start character": 178,
"Start date for period": "2018-08-07",
"Value": 253000000
},
{
"Currency / Unit": "USD",
"End character": 362,
"End date for period": "2018-08-07",
"Label": "cvna:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedTransactionFeeReceived",
"Start character": 359,
"Start date for period": "2018-08-07",
"Value": 4000000
}
] |
10-Q | 0001690820-18-000070 | 2018-08-08T16:21:15+00:00 | 20180630 | CARVANA CO. | On August 7, 2018, we purchased finance receivables that we previously sold to an unrelated party under the 2017 Master Transfer Agreement for a price of approximately $253.0 million and immediately resold such finance receivables to an unrelated party for the same price under a new transfer agreement. We received a fee of approximately $4.0 million for arranging and participating in the transaction. The new transfer agreement is filed herewith as Exhibit 10.1. | [
{
"Currency / Unit": "USD",
"End character": 174,
"End date for period": "2018-08-07",
"Label": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
"Start character": 169,
"Start date for period": "2018-08-07",
"Value": 253000000
},
{
"Currency / Unit": "USD",
"End character": 343,
"End date for period": "2018-08-07",
"Label": "cvna:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedTransactionFeeReceived",
"Start character": 340,
"Start date for period": "2018-08-07",
"Value": 4000000
}
] |
10-Q | 0001564590-18-020586 | 2018-08-08T17:33:27+00:00 | 20180630 | NEXSTAR MEDIA GROUP, INC. | Transaction costs relating to this acquisition, including legal and professional fees of $0.4 million, were expensed as incurred during the six months ended June 30, 2018. No significant transaction costs were incurred during the three months ended June 30, 2018. | [
{
"Currency / Unit": "USD",
"End character": 93,
"End date for period": "2018-06-30",
"Label": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
"Start character": 90,
"Start date for period": "2018-01-01",
"Value": 400000
}
] |
10-Q | 0001564590-18-020586 | 2018-08-08T17:33:27+00:00 | 20180630 | NEXSTAR MEDIA GROUP, INC. | On January 16, 2018, Nexstar borrowed $44.0 million from its revolving credit facility to partially fund the acquisition of LKQD (See Note 3). Through June 2018, Nexstar repaid in full the outstanding principal balance under its revolving loan for total payments of $44.0 million. | [
{
"Currency / Unit": "USD",
"End character": 43,
"End date for period": "2018-01-16",
"Label": "us-gaap:ProceedsFromLinesOfCredit",
"Start character": 39,
"Start date for period": "2018-01-16",
"Value": 44000000
},
{
"Currency / Unit": "USD",
"End character": 271,
"End date for period": "2018-01-16",
"Label": "us-gaap:ProceedsFromLinesOfCredit",
"Start character": 267,
"Start date for period": "2018-01-16",
"Value": 44000000
}
] |
10-Q | 0001564590-18-020586 | 2018-08-08T17:33:27+00:00 | 20180630 | NEXSTAR MEDIA GROUP, INC. | On June 28, 2018, Marshall amended its senior secured credit facility. The amendment refinanced the then outstanding principal balances of Marshall’s term loans and revolving credit facility of $48.8 million and $3.0 million, respectively. The refinancing was funded by Marshall’s new term loan of $51.8 million which Nexstar continues to guarantee. The amendment also extended the maturity date of Marshall’s term loans to December 1, 2019. There were no significant financing costs and lender fees incurred related to Marshall’s refinancing of its senior secured credit facility. As of June 30, 2018, Marshall’s term loans, net of financing costs, had a balance of $51.7 million, of which $1.9 million is in current liabilities. | [
{
"Currency / Unit": "USD",
"End character": 199,
"End date for period": "2018-06-28",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 195,
"Start date for period": "2018-06-28",
"Value": 48800000
},
{
"Currency / Unit": "USD",
"End character": 216,
"End date for period": "2018-06-28",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 213,
"Start date for period": "2018-06-28",
"Value": 3000000
},
{
"Currency / Unit": "USD",
"End character": 303,
"End date for period": "2018-06-28",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 299,
"Start date for period": "2018-06-28",
"Value": 51800000
},
{
"Currency / Unit": "USD",
"End character": 672,
"End date for period": "2018-06-30",
"Label": "us-gaap:LongTermDebt",
"Start character": 668,
"Start date for period": "2018-06-30",
"Value": 51700000
},
{
"Currency / Unit": "USD",
"End character": 695,
"End date for period": "2018-06-30",
"Label": "us-gaap:LongTermDebtCurrent",
"Start character": 692,
"Start date for period": "2018-06-30",
"Value": 1900000
}
] |
10-Q | 0001564590-18-020586 | 2018-08-08T17:33:27+00:00 | 20180630 | NEXSTAR MEDIA GROUP, INC. | In December 2017, the Tax Act was signed into law, which reduced the federal corporate income tax rate from 35% to 21%, or a 14.0% decrease in the effective tax rate. A $1.5 million decrease in permanent differences between the two periods contributed an additional 2.3% decrease in the effective tax rate. These decreases were partially offset by a decrease in nontaxable earnings of $1.3 million, or a 1.6% increase in the effective tax rate. In 2017, the Company released an uncertain tax position resulting in an income tax benefit of $1.6 million, contributing a further 2.0% increase in the effective tax rate between the two periods. | [
{
"Currency / Unit": "pure",
"End character": 110,
"End date for period": "2017-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
"Start character": 108,
"Start date for period": "2017-01-01",
"Value": 0.35000000000000003
},
{
"Currency / Unit": "pure",
"End character": 117,
"End date for period": "2018-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
"Start character": 115,
"Start date for period": "2018-01-01",
"Value": 0.21
},
{
"Currency / Unit": "pure",
"End character": 129,
"End date for period": "2018-06-30",
"Label": "nxst:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent",
"Start character": 125,
"Start date for period": "2018-01-01",
"Value": -0.14
},
{
"Currency / Unit": "USD",
"End character": 173,
"End date for period": "2018-06-30",
"Label": "nxst:IncomeTaxReconciliationPermanentDifferences",
"Start character": 170,
"Start date for period": "2018-04-01",
"Value": -1500000
},
{
"Currency / Unit": "pure",
"End character": 269,
"End date for period": "2018-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
"Start character": 266,
"Start date for period": "2018-04-01",
"Value": -0.023
},
{
"Currency / Unit": "USD",
"End character": 389,
"End date for period": "2018-06-30",
"Label": "us-gaap:IncomeTaxReconciliationTaxExemptIncome",
"Start character": 386,
"Start date for period": "2018-04-01",
"Value": 1300000
},
{
"Currency / Unit": "pure",
"End character": 407,
"End date for period": "2018-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome",
"Start character": 404,
"Start date for period": "2018-04-01",
"Value": 0.016
},
{
"Currency / Unit": "pure",
"End character": 543,
"End date for period": "2018-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome",
"Start character": 540,
"Start date for period": "2018-04-01",
"Value": 0.016
},
{
"Currency / Unit": "pure",
"End character": 579,
"End date for period": "2018-06-30",
"Label": "nxst:EffectiveIncomeTaxRateReconciliationReleaseOfUncertainTaxPosition",
"Start character": 576,
"Start date for period": "2018-04-01",
"Value": 0.02
}
] |
10-Q | 0001564590-18-020586 | 2018-08-08T17:33:27+00:00 | 20180630 | NEXSTAR MEDIA GROUP, INC. | Decreases between the two periods were primarily attributable to (i) the Tax Act, effecting a 14.0% decrease in the effective tax rate, (ii) the liquidation of Media General legal entities that merged with Nexstar in 2017 and resulted in an income tax expense of $1.5 million in 2017, or a 1.9% decrease in the 2018 effective tax rate compared to prior year, (iii) transaction costs attributable to Nexstar’s merger with Media General that were determined to be nondeductible for tax purposes and resulted in an income tax expense of $1.7 million in 2017, or a 2.1% decrease in the 2018 effective tax rate compared to prior year, and (iv) a $1.0 million decrease in permanent differences, resulting in a 2.3% decrease in the 2018 effective tax rate compared to prior year. | [
{
"Currency / Unit": "pure",
"End character": 98,
"End date for period": "2018-06-30",
"Label": "nxst:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent",
"Start character": 94,
"Start date for period": "2018-01-01",
"Value": -0.14
},
{
"Currency / Unit": "USD",
"End character": 267,
"End date for period": "2017-06-30",
"Label": "us-gaap:IncomeTaxReconciliationTaxContingenciesStateAndLocal",
"Start character": 264,
"Start date for period": "2017-01-01",
"Value": 1500000
},
{
"Currency / Unit": "pure",
"End character": 293,
"End date for period": "2018-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal",
"Start character": 290,
"Start date for period": "2018-01-01",
"Value": 0.019
},
{
"Currency / Unit": "USD",
"End character": 538,
"End date for period": "2017-06-30",
"Label": "us-gaap:IncomeTaxReconciliationNondeductibleExpense",
"Start character": 535,
"Start date for period": "2017-01-01",
"Value": 1700000
},
{
"Currency / Unit": "pure",
"End character": 564,
"End date for period": "2018-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
"Start character": 561,
"Start date for period": "2018-01-01",
"Value": 0.021
},
{
"Currency / Unit": "USD",
"End character": 645,
"End date for period": "2018-06-30",
"Label": "nxst:IncomeTaxReconciliationPermanentDifferences",
"Start character": 642,
"Start date for period": "2018-01-01",
"Value": -1000000
},
{
"Currency / Unit": "pure",
"End character": 707,
"End date for period": "2018-06-30",
"Label": "us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
"Start character": 704,
"Start date for period": "2018-01-01",
"Value": -0.023
}
] |
10-Q | 0001564590-18-020586 | 2018-08-08T17:33:27+00:00 | 20180630 | NEXSTAR MEDIA GROUP, INC. | As a result, the associated spectrum asset and liability to surrender spectrum, both amounting to $314.1 million, were derecognized in the second quarter of 2018. | [
{
"Currency / Unit": "USD",
"End character": 104,
"End date for period": "2018-06-30",
"Label": "nxst:SpectrumAssetAndLiabilitySurrenderValue",
"Start character": 99,
"Start date for period": "2018-06-30",
"Value": 314100000
}
] |
10-Q | 0001564590-18-020586 | 2018-08-08T17:33:27+00:00 | 20180630 | NEXSTAR MEDIA GROUP, INC. | This allocation includes $1 billion added to the TV Broadcaster Relocation Fund as part of the Consolidated Appropriations Act, 2018. | [
{
"Currency / Unit": "USD",
"End character": 27,
"End date for period": "2018-06-30",
"Label": "nxst:AmountOfReimbursementForRepackCostAllocatedToTelevisionBroadcasterRelocationFund",
"Start character": 26,
"Start date for period": "2018-01-01",
"Value": 1000000000
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | As of June 30, 2018 and 2017, restricted stock awards and options to purchase 231,905 and 20,375 shares of common stock, respectively, were outstanding but were not included in the computation of diluted earnings per share because the effect would be antidilutive. | [
{
"Currency / Unit": "shares",
"End character": 85,
"End date for period": "2018-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 78,
"Start date for period": "2018-01-01",
"Value": 231905
},
{
"Currency / Unit": "shares",
"End character": 96,
"End date for period": "2017-06-30",
"Label": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"Start character": 90,
"Start date for period": "2017-01-01",
"Value": 20375
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | The Company continually evaluates inventory for potential losses due to excess, obsolete or slow-moving inventory by comparing sales history and sales projections to the inventory on hand. When evidence indicates that the carrying value may not be recoverable, a charge is taken to reduce the inventory to its current net realizable value. At June 30, 2018 and December 31, 2017, the Company has recognized and maintained cumulative charges for potential obsolescence and discontinuance losses of approximately $0.1 million and $0.2 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 516,
"End date for period": "2018-06-30",
"Label": "us-gaap:InventoryValuationReserves",
"Start character": 513,
"Start date for period": "2018-06-30",
"Value": 100000
},
{
"Currency / Unit": "USD",
"End character": 533,
"End date for period": "2017-12-31",
"Label": "us-gaap:InventoryValuationReserves",
"Start character": 530,
"Start date for period": "2017-12-31",
"Value": 200000
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | The Company currently has a share repurchase program to repurchase up to $10 million of its common stock pursuant to Rule 10b-18 of the Securities Exchange Act of 1934. In January 2016, the Company's Board of Directors established the current $10 million repurchase program to replace the prior authorizations. During the six months ended June 30, 2018 and June 30, 2017, the Company repurchased 299,370 shares and 282,856 shares, respectively, of common stock for approximately $2.0 million and $1.8 million, respectively. | [
{
"Currency / Unit": "USD",
"End character": 76,
"End date for period": "2010-05-13",
"Label": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
"Start character": 74,
"Start date for period": "2010-05-13",
"Value": 10000000
},
{
"Currency / Unit": "USD",
"End character": 124,
"End date for period": "2010-05-13",
"Label": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
"Start character": 122,
"Start date for period": "2010-05-13",
"Value": 10000000
},
{
"Currency / Unit": "shares",
"End character": 404,
"End date for period": "2018-06-30",
"Label": "us-gaap:StockRepurchasedDuringPeriodShares",
"Start character": 397,
"Start date for period": "2018-01-01",
"Value": 299370
},
{
"Currency / Unit": "shares",
"End character": 423,
"End date for period": "2017-06-30",
"Label": "us-gaap:StockRepurchasedDuringPeriodShares",
"Start character": 416,
"Start date for period": "2017-01-01",
"Value": 282856
},
{
"Currency / Unit": "USD",
"End character": 484,
"End date for period": "2018-06-30",
"Label": "us-gaap:StockRepurchasedDuringPeriodValue",
"Start character": 481,
"Start date for period": "2018-01-01",
"Value": 2000000
},
{
"Currency / Unit": "USD",
"End character": 501,
"End date for period": "2017-06-30",
"Label": "us-gaap:StockRepurchasedDuringPeriodValue",
"Start character": 498,
"Start date for period": "2017-01-01",
"Value": -1800000
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | In November 2017, the Company filed a Shelf Registration on Form S-3 with the SEC associated with the sale of up to $100 million in corporate securities. The Shelf Registration was declared effective in January 2018. During the six months ended June 30, 2018, the Company issued 30,704 shares of common stock for gross proceeds of $0.2 million as part of its At-The-Market (“ATM”) sales agreement with B. Riley FBR. | [
{
"Currency / Unit": "USD",
"End character": 120,
"End date for period": "2017-11-30",
"Label": "cpix:StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleOfCorporateSecurities",
"Start character": 117,
"Start date for period": "2017-11-01",
"Value": 100000000
},
{
"Currency / Unit": "shares",
"End character": 286,
"End date for period": "2018-06-30",
"Label": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
"Start character": 280,
"Start date for period": "2018-01-01",
"Value": 30704
},
{
"Currency / Unit": "USD",
"End character": 336,
"End date for period": "2018-06-30",
"Label": "us-gaap:ProceedsFromIssuanceOfCommonStock",
"Start character": 333,
"Start date for period": "2018-01-01",
"Value": 200000
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | During the six months ended June 30, 2018, the Company issued 233,330 shares of restricted stock to employees and directors. Restricted stock issued to employees generally cliff-vests on the fourth anniversary of the date of grant and for directors on the one-year anniversary of the date of grant. Stock compensation expense is presented as a component of general and administrative expense in the condensed consolidated statements of operations and comprehensive income (loss). | [
{
"Currency / Unit": "shares",
"End character": 69,
"End date for period": "2018-06-30",
"Label": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"Start character": 62,
"Start date for period": "2018-01-01",
"Value": 233330
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | On July 31, 2017, the Company entered into a Revolving Credit Loan Agreement with Pinnacle Bank ("Pinnacle Agreement"). The Pinnacle Agreement replaced the June 2014 Revolving Credit Loan Agreement with SunTrust Bank, which was to expire on June 30, 2018. The Company had $12.0 million in borrowings under that agreement at June 30, 2018. The Pinnacle Agreement provides for an aggregate principal amount of up to $20 million and has a three-year term expiring on July 31, 2020. The initial revolving line of credit is up to $12 million with the ability to increase the borrowing amount up to $20 million, upon the satisfaction of certain conditions. | [
{
"Currency / Unit": "USD",
"End character": 278,
"End date for period": "2018-06-30",
"Label": "us-gaap:LongTermLineOfCredit",
"Start character": 274,
"Start date for period": "2018-06-30",
"Value": 12000000
},
{
"Currency / Unit": "USD",
"End character": 337,
"End date for period": "2017-07-31",
"Label": "cpix:LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions",
"Start character": 335,
"Start date for period": "2017-07-31",
"Value": 20000000
},
{
"Currency / Unit": "USD",
"End character": 531,
"End date for period": "2017-07-31",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 529,
"Start date for period": "2017-07-31",
"Value": 12000000
},
{
"Currency / Unit": "USD",
"End character": 599,
"End date for period": "2017-07-31",
"Label": "cpix:LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions",
"Start character": 597,
"Start date for period": "2017-07-31",
"Value": 20000000
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | The interest rate on the Pinnacle Agreement is based on LIBOR plus an interest rate spread. There is no LIBOR minimum and the LIBOR pricing provides for an interest rate spread of 1.75% to 2.75% (representing an interest rate of 3.8% at June 30, 2018). In addition, a fee of 0.25% per year is charged on the unused line of credit. Interest and the unused line fee are payable quarterly. Borrowings under the line of credit are collateralized by substantially all of our assets. | [
{
"Currency / Unit": "pure",
"End character": 184,
"End date for period": "2017-07-31",
"Label": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
"Start character": 180,
"Start date for period": "2017-07-31",
"Value": 0.0175
},
{
"Currency / Unit": "pure",
"End character": 193,
"End date for period": "2017-07-31",
"Label": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
"Start character": 189,
"Start date for period": "2017-07-31",
"Value": 0.0275
},
{
"Currency / Unit": "pure",
"End character": 232,
"End date for period": "2018-06-30",
"Label": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
"Start character": 229,
"Start date for period": "2018-06-30",
"Value": 0.038
},
{
"Currency / Unit": "pure",
"End character": 280,
"End date for period": "2017-07-31",
"Label": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
"Start character": 276,
"Start date for period": "2017-07-31",
"Value": 0.0025
}
] |
10-Q | 0001628280-18-011131 | 2018-08-14T17:12:35+00:00 | 20180630 | CUMBERLAND PHARMACEUTICALS INC | In connection with our analysis of the impact of the Tax Act, we have a net tax benefit of $0.1 million as of June 30, 2018. This net tax benefit consists entirely of the release of the valuation allowance against AMT credits that will be realizable under the Tax Act in future periods. The Company does not expect to record further amounts related to the Tax Act, but will continue to evaluate additional Internal Revenue Service guidance as it is released. The Company expects it will continue to pay minimal taxes in future periods through the continued utilization of net operating loss carryforwards, as it is able to achieve taxable income through its operations. | [
{
"Currency / Unit": "USD",
"End character": 95,
"End date for period": "2018-06-30",
"Label": "us-gaap:DeferredTaxAssetsLiabilitiesNetNoncurrent",
"Start character": 92,
"Start date for period": "2018-06-30",
"Value": 100000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | In October 2016, the FASB issued ASU 2016-16, “Income Taxes – Intra-Entity Transfers of Assets Other Than Inventory (Topic 740),” (“ASU 2016-16”) which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The ASU was effective on January 1, 2018 and was adopted by the Company on that date, using the modified retrospective approach. Under this approach, the Company recorded a reduction to its January 1, 2018 opening retained earnings of $305 as a result of prior intra-entity transactions. | [
{
"Currency / Unit": "USD",
"End character": 540,
"End date for period": "2017-12-31",
"Label": "us-gaap:RetainedEarningsAccumulatedDeficit",
"Start character": 537,
"Start date for period": "2017-12-31",
"Value": -305000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company’s performance obligations under long-term agreements with its customers are generally satisfied as over time. Revenue from products or services transferred to customers over time accounted for 23.4% and 22.7% of revenue for the three months ended June 30, 2018 and 2017, respectively, and 24.3% and 22.9% of revenue for the six months ended June 30, 2018 and 2017, respectively. Revenue under these long-term agreements is generally recognized over time either using an input measure based upon the proportion of actual costs incurred to estimated total project costs or an input measure based upon actual labor costs as a percentage of estimated total labor costs, depending upon which measure the Company believes best depicts the Company’s performance to date under the terms of the contract. Revenue recognized over time using an input measure was $29,583 and $19,835 for the three months ended June 30, 2018 and 2017, respectively, and was $54,144 and $41,445 for the six months ended June 30, 2018 and 2017, respectively. A certain portion of the Company’s revenue recognized over time under these long-term agreements is recognized using an output method, specifically units delivered, based upon certain customer acceptance and delivery requirements. Revenue recognized over time using an output measure was $10,893 and $13,049 for the three months ended June 30, 2018 and 2017, respectively, and was $17,554 and $19,012 for the six months ended June 30, 2018 and 2017, respectively. As of June 30, 2018 and December 31, 2017, the Company had contract assets of $29,247 and $25,320, respectively, that were recorded in inventory within the Condensed Consolidated Balance Sheets. At June 30, 2018 and December 31, 2017, the Company had contract liabilities of $3,035 and $1,420, respectively, that were recorded in deferred revenue within the Condensed Consolidated Balance Sheets. | [
{
"Currency / Unit": "pure",
"End character": 209,
"End date for period": "2018-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 205,
"Start date for period": "2018-04-01",
"Value": 0.234
},
{
"Currency / Unit": "pure",
"End character": 219,
"End date for period": "2017-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 215,
"Start date for period": "2017-04-01",
"Value": 0.227
},
{
"Currency / Unit": "pure",
"End character": 305,
"End date for period": "2018-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 301,
"Start date for period": "2018-01-01",
"Value": 0.243
},
{
"Currency / Unit": "pure",
"End character": 315,
"End date for period": "2017-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 311,
"Start date for period": "2017-01-01",
"Value": 0.229
},
{
"Currency / Unit": "USD",
"End character": 964,
"End date for period": "2018-06-30",
"Label": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
"Start character": 958,
"Start date for period": "2018-01-01",
"Value": 54144000
},
{
"Currency / Unit": "USD",
"End character": 976,
"End date for period": "2017-06-30",
"Label": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
"Start character": 970,
"Start date for period": "2017-01-01",
"Value": 41445000
},
{
"Currency / Unit": "USD",
"End character": 1335,
"End date for period": "2018-06-30",
"Label": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
"Start character": 1329,
"Start date for period": "2018-04-01",
"Value": 10893000
},
{
"Currency / Unit": "USD",
"End character": 1347,
"End date for period": "2017-06-30",
"Label": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
"Start character": 1341,
"Start date for period": "2017-04-01",
"Value": 13049000
},
{
"Currency / Unit": "USD",
"End character": 1428,
"End date for period": "2018-06-30",
"Label": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
"Start character": 1422,
"Start date for period": "2018-01-01",
"Value": 17554000
},
{
"Currency / Unit": "USD",
"End character": 1440,
"End date for period": "2017-06-30",
"Label": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
"Start character": 1434,
"Start date for period": "2017-01-01",
"Value": 19012000
},
{
"Currency / Unit": "USD",
"End character": 1589,
"End date for period": "2018-06-30",
"Label": "us-gaap:ContractWithCustomerAssetNet",
"Start character": 1583,
"Start date for period": "2018-06-30",
"Value": 29247000
},
{
"Currency / Unit": "USD",
"End character": 1796,
"End date for period": "2017-12-31",
"Label": "us-gaap:ContractWithCustomerLiability",
"Start character": 1791,
"Start date for period": "2017-12-31",
"Value": 1420000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The majority of the Company’s revenue is from products and services transferred to customers at a point in time, which accounted for approximately 76.6% and 77.3% of revenue for the three months ended June 30, 2018 and 2017, respectively. Revenue from products and services transferred to customers at a point in time accounted for approximately 75.7% and 77.1% of revenue for the six months ended June 30, 2018 and 2017, respectively. The Company recognizes revenue at the point in time in which the customer obtains control of the product or service, which is generally when product title passes to the customer upon shipment or the service has been rendered to the customer. In limited cases, title does not transfer and revenue is not recognized until the customer has received the products at its physical location. | [
{
"Currency / Unit": "pure",
"End character": 151,
"End date for period": "2018-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 147,
"Start date for period": "2018-04-01",
"Value": 0.766
},
{
"Currency / Unit": "pure",
"End character": 161,
"End date for period": "2017-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 157,
"Start date for period": "2017-04-01",
"Value": 0.773
},
{
"Currency / Unit": "pure",
"End character": 350,
"End date for period": "2018-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 346,
"Start date for period": "2018-01-01",
"Value": 0.757
},
{
"Currency / Unit": "pure",
"End character": 360,
"End date for period": "2017-06-30",
"Label": "fstr:RevenueFromContractWithCustomerPercentage",
"Start character": 356,
"Start date for period": "2017-01-01",
"Value": 0.771
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | Significant changes in contract assets during the six months ended June 30, 2018 include transfers to receivables from contract assets recognized at the beginning of the period of $10,872. Significant changes in contract liabilities during the six months ended June 30, 2018 include $740 of revenue recognized that was included in the contract liability at the beginning of the period, and increases of $2,488 due to billings in excess of costs, excluding amounts recognized as revenue during the period. | [
{
"Currency / Unit": "USD",
"End character": 187,
"End date for period": "2018-06-30",
"Label": "us-gaap:ContractWithCustomerAssetReclassifiedToReceivable",
"Start character": 181,
"Start date for period": "2018-01-01",
"Value": 10872000
},
{
"Currency / Unit": "USD",
"End character": 409,
"End date for period": "2018-06-30",
"Label": "fstr:ContractwithCustomerLiabilityIncreasefromCashReceipts",
"Start character": 404,
"Start date for period": "2018-01-01",
"Value": 2488000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | As of June 30, 2018, the Company has approximately $231,252 of remaining performance obligations, which is also referred to as backlog. Approximately 11.7% of the June 30, 2018 backlog is related to projects that are anticipated to extend beyond June 30, 2019. | [
{
"Currency / Unit": "USD",
"End character": 59,
"End date for period": "2018-06-30",
"Label": "us-gaap:RevenueRemainingPerformanceObligation",
"Start character": 52,
"Start date for period": "2018-06-30",
"Value": 231252000
},
{
"Currency / Unit": "pure",
"End character": 154,
"End date for period": "2018-06-30",
"Label": "fstr:RevenueRemainingPerformanceObligationPercentage",
"Start character": 150,
"Start date for period": "2018-06-30",
"Value": 0.117
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | Intangible assets are amortized over their useful lives, which range from 4 to 25 years, with a total weighted average amortization period of approximately 15 years at June 30, 2018. Amortization expense for the three months ended June 30, 2018 and 2017 was $1,775 and $1,695, respectively. Amortization expense for the six months ended June 30, 2018 and 2017 was $3,560 and $3,454, respectively. | [
{
"Currency / Unit": "USD",
"End character": 264,
"End date for period": "2018-06-30",
"Label": "us-gaap:AmortizationOfIntangibleAssets",
"Start character": 259,
"Start date for period": "2018-04-01",
"Value": 1775000
},
{
"Currency / Unit": "USD",
"End character": 275,
"End date for period": "2017-06-30",
"Label": "us-gaap:AmortizationOfIntangibleAssets",
"Start character": 270,
"Start date for period": "2017-04-01",
"Value": 1695000
},
{
"Currency / Unit": "USD",
"End character": 370,
"End date for period": "2018-06-30",
"Label": "us-gaap:AmortizationOfIntangibleAssets",
"Start character": 365,
"Start date for period": "2018-01-01",
"Value": 3560000
},
{
"Currency / Unit": "USD",
"End character": 381,
"End date for period": "2017-06-30",
"Label": "us-gaap:AmortizationOfIntangibleAssets",
"Start character": 376,
"Start date for period": "2017-01-01",
"Value": 3454000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | During the three months ended June 30, 2018, the Company sold 54.5 acres of land in exchange for cash proceeds of $2,047, resulting in a loss of $269. Depreciation expense for the three months ended June 30, 2018 and 2017 was $2,938 and $3,245, respectively. Depreciation expense for the six months ended June 30, 2018 and 2017 was $5,882 and $6,527, respectively. | [
{
"Currency / Unit": "utr:acre",
"End character": 66,
"End date for period": "2018-06-30",
"Label": "us-gaap:AreaOfLand",
"Start character": 62,
"Start date for period": "2018-06-30",
"Value": 54.5
},
{
"Currency / Unit": "USD",
"End character": 120,
"End date for period": "2018-06-30",
"Label": "us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment",
"Start character": 115,
"Start date for period": "2018-04-01",
"Value": 2047000
},
{
"Currency / Unit": "USD",
"End character": 149,
"End date for period": "2018-06-30",
"Label": "us-gaap:GainLossOnSaleOfPropertiesBeforeApplicableIncomeTaxes",
"Start character": 146,
"Start date for period": "2018-04-01",
"Value": -269000
},
{
"Currency / Unit": "USD",
"End character": 232,
"End date for period": "2018-06-30",
"Label": "us-gaap:Depreciation",
"Start character": 227,
"Start date for period": "2018-04-01",
"Value": 2938000
},
{
"Currency / Unit": "USD",
"End character": 243,
"End date for period": "2017-06-30",
"Label": "us-gaap:Depreciation",
"Start character": 238,
"Start date for period": "2017-04-01",
"Value": 3245000
},
{
"Currency / Unit": "USD",
"End character": 338,
"End date for period": "2018-06-30",
"Label": "us-gaap:Depreciation",
"Start character": 333,
"Start date for period": "2018-01-01",
"Value": 5882000
},
{
"Currency / Unit": "USD",
"End character": 349,
"End date for period": "2017-06-30",
"Label": "us-gaap:Depreciation",
"Start character": 344,
"Start date for period": "2017-01-01",
"Value": 6527000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company is a member of a joint venture, L B Pipe & Coupling Products, LLC (“L B Pipe JV”), in which it maintains a 45% ownership interest. L B Pipe JV manufactures, markets, and sells various machined components and precision coupling products for the energy, water well, and construction markets and is scheduled to terminate on June 30, 2019. | [
{
"Currency / Unit": "pure",
"End character": 121,
"End date for period": "2018-06-30",
"Label": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"Start character": 119,
"Start date for period": "2018-06-30",
"Value": 0.45
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | During the quarter ended September 30, 2017, pursuant to the limited liability company agreement, the Company determined to sell its 45% ownership interest to the other 45% equity holder. The Company concluded that it had met the criteria under applicable guidance for a long-lived asset to be held for sale, and, accordingly, reclassified its L B Pipe JV investment of $4,288 as a current asset held for sale within other current assets. The asset was subsequently remeasured to its fair market value of $3,875. The difference between the fair market value and the Company's carrying amount of $413 was recorded as an other-than-temporary impairment during 2017. | [
{
"Currency / Unit": "pure",
"End character": 135,
"End date for period": "2018-06-30",
"Label": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"Start character": 133,
"Start date for period": "2018-06-30",
"Value": 0.45
},
{
"Currency / Unit": "pure",
"End character": 171,
"End date for period": "2018-06-30",
"Label": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"Start character": 169,
"Start date for period": "2018-06-30",
"Value": 0.45
},
{
"Currency / Unit": "USD",
"End character": 376,
"End date for period": "2017-09-30",
"Label": "us-gaap:EquityMethodInvestments",
"Start character": 371,
"Start date for period": "2017-09-30",
"Value": -4288000
},
{
"Currency / Unit": "USD",
"End character": 511,
"End date for period": "2017-03-31",
"Label": "us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
"Start character": 506,
"Start date for period": "2017-03-31",
"Value": 3875000
},
{
"Currency / Unit": "USD",
"End character": 599,
"End date for period": "2017-12-31",
"Label": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
"Start character": 596,
"Start date for period": "2017-01-01",
"Value": 413000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | At June 30, 2018 and December 31, 2017, the Company had a nonconsolidated equity method investment of $159 and $162, respectively. | [
{
"Currency / Unit": "USD",
"End character": 106,
"End date for period": "2018-06-30",
"Label": "us-gaap:EquityMethodInvestments",
"Start character": 103,
"Start date for period": "2018-06-30",
"Value": 159000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company recorded equity in the income of L B Pipe JV of $0 and $150 for the three months ended June 30, 2018 and 2017, respectively. For the six months ended June 30, 2018 and 2017, the Company recorded equity in the loss of L B Pipe JV of $0 and $48, respectively. | [
{
"Currency / Unit": "USD",
"End character": 62,
"End date for period": "2018-06-30",
"Label": "us-gaap:IncomeLossFromEquityMethodInvestments",
"Start character": 61,
"Start date for period": "2018-04-01",
"Value": 0
},
{
"Currency / Unit": "USD",
"End character": 71,
"End date for period": "2017-06-30",
"Label": "us-gaap:IncomeLossFromEquityMethodInvestments",
"Start character": 68,
"Start date for period": "2017-04-01",
"Value": 150000
},
{
"Currency / Unit": "USD",
"End character": 106,
"End date for period": "2018-06-30",
"Label": "us-gaap:IncomeLossFromEquityMethodInvestments",
"Start character": 105,
"Start date for period": "2018-04-01",
"Value": 0
},
{
"Currency / Unit": "USD",
"End character": 254,
"End date for period": "2017-06-30",
"Label": "us-gaap:IncomeLossFromEquityMethodInvestments",
"Start character": 252,
"Start date for period": "2017-01-01",
"Value": -48000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | During 2016, the Company and the other 45% member each executed a revolving line of credit with L B Pipe JV with an available limit of $1,350. The Company and the other 45% member each loaned $1,235 to L B Pipe JV in an effort to maintain compliance with L B Pipe JV’s debt covenants with an unaffiliated bank. The Company is to receive its outstanding loan balance, including accrued interest, at the 45% equity holder sale date. | [
{
"Currency / Unit": "pure",
"End character": 41,
"End date for period": "2016-12-31",
"Label": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"Start character": 39,
"Start date for period": "2016-12-31",
"Value": 0.45
},
{
"Currency / Unit": "USD",
"End character": 141,
"End date for period": "2016-12-31",
"Label": "fstr:LineOfCreditMaximumLendingCapacity",
"Start character": 136,
"Start date for period": "2016-12-31",
"Value": 1350000
},
{
"Currency / Unit": "pure",
"End character": 171,
"End date for period": "2016-12-31",
"Label": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"Start character": 169,
"Start date for period": "2016-12-31",
"Value": 0.45
},
{
"Currency / Unit": "USD",
"End character": 198,
"End date for period": "2016-12-31",
"Label": "us-gaap:DueFromJointVenturesCurrent",
"Start character": 193,
"Start date for period": "2016-12-31",
"Value": 1235000
},
{
"Currency / Unit": "pure",
"End character": 404,
"End date for period": "2016-12-31",
"Label": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"Start character": 402,
"Start date for period": "2016-12-31",
"Value": 0.45
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company is leasing five acres of land and two facilities to L B Pipe JV through June 30, 2019, with a 5.5 year renewal period. The current monthly lease payments approximate $17, with a balloon payment of approximately $488, which is required to be paid either at the termination of the lease, allocated over the renewal period, or during the initial term of the lease. This lease qualifies as a direct financing lease under the applicable guidance in ASC 840-30, “Leases.” | [
{
"Currency / Unit": "utr:acre",
"End character": 27,
"End date for period": "2018-06-30",
"Label": "us-gaap:AreaOfLand",
"Start character": 23,
"Start date for period": "2018-06-30",
"Value": 5
},
{
"Currency / Unit": "fstr:facility",
"End character": 49,
"End date for period": "2018-06-30",
"Label": "us-gaap:CapitalLeasedAssetsNumberOfUnits",
"Start character": 46,
"Start date for period": "2018-06-30",
"Value": 2
},
{
"Currency / Unit": "USD",
"End character": 181,
"End date for period": "2018-06-30",
"Label": "fstr:CapitalLeasesMonthlyRent",
"Start character": 179,
"Start date for period": "2018-01-01",
"Value": 17000
},
{
"Currency / Unit": "USD",
"End character": 227,
"End date for period": "2018-06-30",
"Label": "fstr:CapitalLeasesBalloonPaymentInDirectFinancingLeases",
"Start character": 224,
"Start date for period": "2018-06-30",
"Value": 488000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | On November 7, 2016, the Company, its domestic subsidiaries, and certain of its Canadian subsidiaries entered into the Second Amendment (the “Second Amendment”) to the Second Amended and Restated Credit Agreement dated March 13, 2015 and as amended by the First Amendment dated June 29, 2016 (the “Amended and Restated Credit Agreement”), with PNC Bank, N.A., Bank of America, N.A., Wells Fargo Bank, N.A., Citizens Bank of Pennsylvania, and Branch Banking and Trust Company. This Second Amendment modified the Amended and Restated Credit Agreement, which had a maximum revolving credit line of $275,000. The Second Amendment reduced the permitted revolving credit borrowings to $195,000 and provided for additional term loan borrowing of $30,000 (the “Term Loan”). During 2017, the Company paid off the balance of the Term Loan. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Second Amendment or Amended and Restated Credit Agreement filed as Exhibit 10.3 to the Company's Annual Report on Form 10-K for the year ended December 31, 2017, as applicable. | [
{
"Currency / Unit": "USD",
"End character": 603,
"End date for period": "2016-06-29",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 596,
"Start date for period": "2016-06-29",
"Value": 275000000
},
{
"Currency / Unit": "USD",
"End character": 687,
"End date for period": "2016-11-07",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 680,
"Start date for period": "2016-11-07",
"Value": 195000000
},
{
"Currency / Unit": "USD",
"End character": 746,
"End date for period": "2016-11-07",
"Label": "us-gaap:LoansPayable",
"Start character": 740,
"Start date for period": "2016-11-07",
"Value": 30000000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Second Amendment further provided for modifications to the financial covenants as defined in the Amended and Restated Credit Agreement. The Second Amendment calls for the elimination of the Maximum Leverage Ratio covenant through the quarter ended June 30, 2018. After that period, the Maximum Gross Leverage Ratio covenant will be reinstated to require a maximum ratio of 4.25 Consolidated Indebtedness to 1.00 Gross Leverage for the quarter ending September 30, 2018, and 3.75 to 1.00 for all periods thereafter until the maturity date of the credit facility. The Second Amendment also includes a Minimum Last Twelve Months EBITDA covenant (“Minimum EBITDA”). For the quarter ended December 31, 2016 through the quarter ended June 30, 2017, the Minimum EBITDA had to be at least $18,500. For each quarter thereafter, through the quarter ended June 30, 2018, the Minimum EBITDA requirement increased by various increments. At June 30, 2018, the Minimum EBITDA requirement was $31,000. After the quarter ended June 30, 2018, the Minimum EBITDA covenant was eliminated through the remainder of the Amended and Restated Credit Agreement. The Second Amendment also includes a Minimum Fixed Charge Coverage Ratio covenant. The covenant represents the ratio of the Company’s fixed charges to the last twelve months of EBITDA, and is required to be a minimum of 1.00 to 1.00 through the quarter ended December 31, 2017 and 1.25 to 1.00 for each quarter thereafter through the maturity of the credit facility. The final financial covenant included in the Second Amendment was a Minimum Liquidity covenant which called for a minimum of $25,000 in undrawn availability on the revolving credit loan at all times through the quarter ended June 30, 2018. | [
{
"Currency / Unit": "pure",
"End character": 381,
"End date for period": "2016-11-07",
"Label": "fstr:LeverageRatioInSeventhQuarter",
"Start character": 377,
"Start date for period": "2016-11-07",
"Value": 4.25
},
{
"Currency / Unit": "pure",
"End character": 482,
"End date for period": "2016-11-07",
"Label": "fstr:LeverageRatioThereafter",
"Start character": 478,
"Start date for period": "2016-11-07",
"Value": 3.75
},
{
"Currency / Unit": "USD",
"End character": 792,
"End date for period": "2017-06-30",
"Label": "fstr:EbitdaRequired",
"Start character": 786,
"Start date for period": "2016-10-01",
"Value": 18500000
},
{
"Currency / Unit": "USD",
"End character": 988,
"End date for period": "2018-06-30",
"Label": "fstr:EbitdaRequiredForSeventhQuarter",
"Start character": 982,
"Start date for period": "2018-04-01",
"Value": 31000000
},
{
"Currency / Unit": "pure",
"End character": 1364,
"End date for period": "2017-12-31",
"Label": "fstr:FixedChargeCoverageRatio",
"Start character": 1360,
"Start date for period": "2017-10-01",
"Value": 1
},
{
"Currency / Unit": "pure",
"End character": 1425,
"End date for period": "2018-06-30",
"Label": "fstr:FixedChargeCoverageRatioAfterFifthQuarter",
"Start character": 1421,
"Start date for period": "2018-01-01",
"Value": 1.25
},
{
"Currency / Unit": "USD",
"End character": 1639,
"End date for period": "2018-06-30",
"Label": "fstr:LiquidityCovenant",
"Start character": 1633,
"Start date for period": "2018-01-01",
"Value": 25000000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Second Amendment includes several changes to certain non-financial covenants as defined in the Amended and Restated Credit Agreement. Through the maturity date of the loan, the Company is prohibited from making any future acquisitions. The limitation on permitted annual distributions of dividends or redemptions of the Company’s stock was decreased from $4,000 to $1,700. The aggregate limitation on loans to and investments in non-loan parties was decreased from $10,000 to $5,000. Furthermore, the limitation on asset sales has been decreased from $25,000 annually with a carryover of up to $15,000 from the prior year to $25,000 in the aggregate through the maturity date of the credit facility. | [
{
"Currency / Unit": "USD",
"End character": 365,
"End date for period": "2016-06-29",
"Label": "fstr:MaximumDividendsAllowed",
"Start character": 360,
"Start date for period": "2016-06-29",
"Value": 4000000
},
{
"Currency / Unit": "USD",
"End character": 375,
"End date for period": "2016-11-07",
"Label": "fstr:MaximumDividendsAllowed",
"Start character": 370,
"Start date for period": "2016-11-07",
"Value": 1700000
},
{
"Currency / Unit": "USD",
"End character": 476,
"End date for period": "2016-06-29",
"Label": "fstr:LoansAndAdvancesLimit",
"Start character": 470,
"Start date for period": "2016-06-29",
"Value": 10000000
},
{
"Currency / Unit": "USD",
"End character": 486,
"End date for period": "2016-11-07",
"Label": "fstr:LoansAndAdvancesLimit",
"Start character": 481,
"Start date for period": "2016-11-07",
"Value": 5000000
},
{
"Currency / Unit": "USD",
"End character": 562,
"End date for period": "2016-06-29",
"Label": "fstr:MaximumAssetSalesAllowed",
"Start character": 556,
"Start date for period": "2016-06-29",
"Value": 25000000
},
{
"Currency / Unit": "USD",
"End character": 605,
"End date for period": "2016-06-29",
"Label": "fstr:CarryoverOfAssetSalesAllowed",
"Start character": 599,
"Start date for period": "2016-06-29",
"Value": 15000000
},
{
"Currency / Unit": "USD",
"End character": 636,
"End date for period": "2016-06-29",
"Label": "fstr:MaximumAssetSalesAllowed",
"Start character": 630,
"Start date for period": "2016-06-29",
"Value": 25000000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Second Amendment provided for the elimination of the three lowest tiers of the pricing grid that had previously been defined in the First Amendment. Upon execution of the Second Amendment through the quarter ended March 31, 2018, the Company was locked into the highest tier of the pricing grid, which provided for pricing of the prime rate plus 225 basis points on base rate loans and the applicable LIBOR rate plus 325 basis points on euro rate loans. For each quarter after March 31, 2018 and through the maturity date of the credit facility, the Company’s position on the pricing grid is governed by a Minimum Net Leverage ratio, which is the ratio of Consolidated Indebtedness less cash on hand in excess of $15,000 to EBITDA. If, after March 31, 2018, the Minimum Net Leverage ratio positions the Company on the lowest tier of the pricing grid, pricing will be the prime rate plus 150 basis points on base rate loans or the applicable LIBOR rate plus 250 basis points on euro rate loans. | [
{
"Currency / Unit": "USD",
"End character": 724,
"End date for period": "2016-11-07",
"Label": "fstr:CarryoverOfAssetSalesAllowed",
"Start character": 718,
"Start date for period": "2016-11-07",
"Value": 15000000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | At June 30, 2018, L.B. Foster had outstanding letters of credit of approximately $425 and had net available borrowing capacity of $71,708. The maturity date of the facility is March 13, 2020. | [
{
"Currency / Unit": "USD",
"End character": 85,
"End date for period": "2018-06-30",
"Label": "us-gaap:LineOfCredit",
"Start character": 82,
"Start date for period": "2018-06-30",
"Value": 425000
},
{
"Currency / Unit": "USD",
"End character": 137,
"End date for period": "2018-06-30",
"Label": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
"Start character": 131,
"Start date for period": "2018-06-30",
"Value": 71708000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | A subsidiary of the Company has a credit facility with NatWest Bank for its United Kingdom operations, which includes an overdraft availability of £1,500 pounds sterling (approximately $1,981 at June 30, 2018). This credit facility supports the subsidiary’s working capital requirements and is collateralized by substantially all of the assets of its United Kingdom operations. The interest rate on this facility is the financial institution’s base rate plus 2.50%. Outstanding performance bonds reduce availability under this credit facility. The subsidiary of the Company had no outstanding borrowings under this credit facility at June 30, 2018. There was approximately $404 in outstanding guarantees (as defined in the underlying agreement) at June 30, 2018. This credit facility was renewed during the fourth quarter of 2017 with all underlying terms and conditions remaining unchanged as a result of the renewal. It is the Company’s intention to renew this credit facility with NatWest Bank during the annual review within the fourth quarter of 2018. | [
{
"Currency / Unit": "GBP",
"End character": 153,
"End date for period": "2018-06-30",
"Label": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
"Start character": 148,
"Start date for period": "2018-06-30",
"Value": 1500000
},
{
"Currency / Unit": "pure",
"End character": 463,
"End date for period": "2018-06-30",
"Label": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
"Start character": 459,
"Start date for period": "2018-01-01",
"Value": 0.025
},
{
"Currency / Unit": "USD",
"End character": 580,
"End date for period": "2018-06-30",
"Label": "us-gaap:LineOfCredit",
"Start character": 578,
"Start date for period": "2018-06-30",
"Value": 0
},
{
"Currency / Unit": "USD",
"End character": 677,
"End date for period": "2018-06-30",
"Label": "us-gaap:LineOfCredit",
"Start character": 674,
"Start date for period": "2018-06-30",
"Value": 404000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The United Kingdom credit facility contains certain financial covenants that require the subsidiary to maintain senior interest and cash flow coverage ratios. The subsidiary was in compliance with these financial covenants at June 30, 2018. The subsidiary had available borrowing capacity of $1,577 at June 30, 2018. | [
{
"Currency / Unit": "USD",
"End character": 298,
"End date for period": "2018-06-30",
"Label": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
"Start character": 293,
"Start date for period": "2018-06-30",
"Value": 1577000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | Statements of Operations. For the three months ended June 30, 2018 and 2017, interest income from interest rate swaps was $1 and expense of $114, respectively. Interest expense from the interest rate swaps was $34 and $204 for the six months ended June 30, 2018 and 2017, respectively. | [
{
"Currency / Unit": "USD",
"End character": 65,
"End date for period": "2018-06-30",
"Label": "us-gaap:InvestmentIncomeInterest",
"Start character": 64,
"Start date for period": "2018-04-01",
"Value": -1000
},
{
"Currency / Unit": "USD",
"End character": 144,
"End date for period": "2017-06-30",
"Label": "us-gaap:InterestExpense",
"Start character": 141,
"Start date for period": "2017-04-01",
"Value": 114000
},
{
"Currency / Unit": "USD",
"End character": 213,
"End date for period": "2018-06-30",
"Label": "us-gaap:InterestExpense",
"Start character": 211,
"Start date for period": "2018-01-01",
"Value": 34000
},
{
"Currency / Unit": "USD",
"End character": 222,
"End date for period": "2017-06-30",
"Label": "us-gaap:InterestExpense",
"Start character": 219,
"Start date for period": "2017-01-01",
"Value": 204000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company applies the provisions of ASC 718, “Compensation – Stock Compensation,” to account for the Company’s stock-based compensation. Stock-based compensation cost is measured at the grant date based on the calculated fair value of the award and is recognized over the employees’ requisite service period. The Company recorded stock compensation expense related to fully-vested stock awards, restricted stock awards, and performance unit awards of $822 and $558 for the three-month periods ended June 30, 2018 and 2017, respectively, and $1,904 and $725 for the six-month periods ended June 30, 2018 and 2017, respectively. At June 30, 2018, unrecognized compensation expense for awards that the Company expects to vest approximated $5,561. The Company will recognize this expense over the upcoming 3.8 years through April 2022. | [
{
"Currency / Unit": "USD",
"End character": 457,
"End date for period": "2018-06-30",
"Label": "us-gaap:ShareBasedCompensation",
"Start character": 454,
"Start date for period": "2018-04-01",
"Value": 822000
},
{
"Currency / Unit": "USD",
"End character": 466,
"End date for period": "2017-06-30",
"Label": "us-gaap:ShareBasedCompensation",
"Start character": 463,
"Start date for period": "2017-04-01",
"Value": 558000
},
{
"Currency / Unit": "USD",
"End character": 549,
"End date for period": "2018-06-30",
"Label": "us-gaap:ShareBasedCompensation",
"Start character": 544,
"Start date for period": "2018-01-01",
"Value": 1904000
},
{
"Currency / Unit": "USD",
"End character": 558,
"End date for period": "2017-06-30",
"Label": "us-gaap:ShareBasedCompensation",
"Start character": 555,
"Start date for period": "2017-01-01",
"Value": 725000
},
{
"Currency / Unit": "USD",
"End character": 744,
"End date for period": "2018-06-30",
"Label": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"Start character": 739,
"Start date for period": "2018-06-30",
"Value": 5561000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company has three retirement plans that cover its hourly and salaried employees in the United States: one defined benefit plan, which is frozen, and two defined contribution plans. Employees are eligible to participate in the appropriate plan based on employment classification. The Company’s contributions to the defined benefit and defined contribution plans are governed by the Employee Retirement Income Security Act of 1974 (“ERISA”) and the Company’s policy and investment guidelines applicable to each respective plan. The Company’s policy is to contribute at least the minimum in accordance with the funding standards of ERISA. | [
{
"Currency / Unit": "fstr:plan",
"End character": 21,
"End date for period": "2018-06-30",
"Label": "fstr:NumberOfRetirementPlans",
"Start character": 16,
"Start date for period": "2018-01-01",
"Value": 3
},
{
"Currency / Unit": "fstr:plan",
"End character": 156,
"End date for period": "2018-06-30",
"Label": "fstr:DefinedContributionPlanNumber",
"Start character": 153,
"Start date for period": "2018-01-01",
"Value": 2
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company maintains two defined contribution plans for its employees in Canada, as well as a post-retirement benefit plan. The Company also maintains two defined contribution plans and a defined benefit plan for its employees in the United Kingdom. | [
{
"Currency / Unit": "fstr:plan",
"End character": 25,
"End date for period": "2018-06-30",
"Label": "fstr:DefinedContributionPlanNumber",
"Start character": 22,
"Start date for period": "2018-01-01",
"Value": 2
},
{
"Currency / Unit": "fstr:plan",
"End character": 155,
"End date for period": "2018-06-30",
"Label": "fstr:DefinedContributionPlanNumber",
"Start character": 152,
"Start date for period": "2018-01-01",
"Value": 2
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | United Kingdom regulations require trustees to adopt a prudent approach to funding required contributions to defined benefit pension plans. Employer contributions of approximately $247 are anticipated to the United Kingdom Rail Technologies pension plan during 2018. For the six months ended June 30, 2018, the Company contributed approximately $128 to the plan. | [
{
"Currency / Unit": "USD",
"End character": 184,
"End date for period": "2018-06-30",
"Label": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
"Start character": 181,
"Start date for period": "2018-06-30",
"Value": 247000
},
{
"Currency / Unit": "USD",
"End character": 349,
"End date for period": "2018-06-30",
"Label": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
"Start character": 346,
"Start date for period": "2018-01-01",
"Value": 128000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | The Company sponsors six defined contribution plans for hourly and salaried employees across our domestic and international facilities. The following table summarizes the expense associated with the contributions made to these plans: | [
{
"Currency / Unit": "fstr:plan",
"End character": 24,
"End date for period": "2018-06-30",
"Label": "fstr:DefinedContributionPlanNumber",
"Start character": 21,
"Start date for period": "2018-01-01",
"Value": 6
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | Included within the above table are concrete tie warranty reserves of approximately $7,668 and $7,595 at June 30, 2018 and December 31, 2017, respectively. | [
{
"Currency / Unit": "USD",
"End character": 90,
"End date for period": "2018-06-30",
"Label": "us-gaap:StandardProductWarrantyAccrual",
"Start character": 85,
"Start date for period": "2018-06-30",
"Value": 7668000
},
{
"Currency / Unit": "USD",
"End character": 101,
"End date for period": "2017-12-31",
"Label": "us-gaap:StandardProductWarrantyAccrual",
"Start character": 96,
"Start date for period": "2017-12-31",
"Value": 7595000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | On July 12, 2011, UPRR notified (the “UPRR Notice”) the Company and its subsidiary, CXT Incorporated (“CXT”), of a warranty claim under CXT’s 2005 supply contract relating to the sale of pre-stressed concrete railroad ties to UPRR. UPRR asserted that a significant percentage of concrete ties manufactured in 2006 through 2011 at CXT’s Grand Island, NE facility failed to meet contract specifications, had workmanship defects and were cracking and failing prematurely. Of the 3 million ties manufactured between 1998 and 2011 from the Grand Island, NE facility, approximately 1.6 million ties were sold during the period UPRR had claimed nonconformance. The 2005 contract called for each concrete tie which failed to conform to the specifications or had a material defect in workmanship to be replaced with 1.5 new concrete ties, provided, that, within five years of the sale of a concrete tie, UPRR notified CXT of such failure to conform or such defect in workmanship. The UPRR | [
{
"Currency / Unit": "fstr:tie",
"End character": 477,
"End date for period": "2018-06-30",
"Label": "fstr:ConcreteTiesManufactured",
"Start character": 476,
"Start date for period": "2018-01-01",
"Value": 3000000
},
{
"Currency / Unit": "fstr:tie",
"End character": 579,
"End date for period": "2018-06-30",
"Label": "fstr:ConcreteTiesManufactured",
"Start character": 576,
"Start date for period": "2018-01-01",
"Value": 1600000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | During 2012, the Company completed sufficient testing and analysis to further understand this matter. Based upon testing results and expert analysis, the Company believed it discovered conditions, which largely related to the 2006 to 2007 manufacturing period, that can shorten the life of the concrete ties produced during this period. During the fourth quarter of 2012 and first quarter of 2013, the Company reached agreement with UPRR on several matters including a tie rating process for the Company and UPRR to work together to identify, prioritize, and replace defective ties that meet the criteria for replacement. This process applies to the ties the Company shipped to UPRR from its Grand Island, NE facility from 1998 to 2011. During most of this period, the Company’s warranty policy for UPRR carried a 5-year warranty with a 1.5:1 replacement ratio for any defective ties. In order to accommodate UPRR and other customer concerns, the Company also reverted to a previously used warranty policy providing a 15-year warranty with a 1:1 replacement ratio. This change provided an additional 10 years of warranty protection. In the amended 2005 supply agreement, the Company and UPRR also extended the supply of Tucson ties by five years and agreed on a cash payment of $12,000 to UPRR as compensation for concrete ties already replaced by UPRR during the investigation period. | [
{
"Currency / Unit": "pure",
"End character": 840,
"End date for period": "2012-12-31",
"Label": "fstr:WarrantyRatio",
"Start character": 837,
"Start date for period": "2012-01-01",
"Value": 1.5
},
{
"Currency / Unit": "pure",
"End character": 1043,
"End date for period": "2012-12-31",
"Label": "fstr:WarrantyRatio",
"Start character": 1042,
"Start date for period": "2012-01-01",
"Value": 1
},
{
"Currency / Unit": "USD",
"End character": 1285,
"End date for period": "2012-12-31",
"Label": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
"Start character": 1279,
"Start date for period": "2012-01-01",
"Value": 12000000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | During 2012, as a result of the testing that the Company conducted on concrete ties manufactured at its former Grand Island, NE facility and the developments related to UPRR and other customer matters, the Company recorded pre-tax warranty charges of $22,000 in “Cost of Goods Sold” within its Rail Products and Services segment based on the Company’s estimate of the number of defective concrete ties that will ultimately require replacement during the applicable warranty periods. | [
{
"Currency / Unit": "USD",
"End character": 258,
"End date for period": "2012-12-31",
"Label": "us-gaap:ProductWarrantyExpense",
"Start character": 252,
"Start date for period": "2012-01-01",
"Value": 22000000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | During 2014, the Company increased its accrual by an additional $8,766 based on revised estimates of ties to be replaced based upon scientific testing and other analysis, adjusted for ties already provided to UPRR. The Company continued to work with UPRR to identify, replace, and reconcile defective ties related to the warranty claim in accordance with the amended 2005 | [
{
"Currency / Unit": "USD",
"End character": 70,
"End date for period": "2014-12-31",
"Label": "us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease",
"Start character": 65,
"Start date for period": "2014-01-01",
"Value": 8766000
}
] |
10-Q | 0000352825-18-000034 | 2018-07-31T09:19:07+00:00 | 20180630 | FOSTER L B CO | At June 30, 2018 and December 31, 2017, the Company maintained environmental reserves approximating $6,144 and $6,144, respectively. The following table sets forth the Company’s environmental obligation: | [
{
"Currency / Unit": "USD",
"End character": 106,
"End date for period": "2018-06-30",
"Label": "us-gaap:AccrualForEnvironmentalLossContingencies",
"Start character": 101,
"Start date for period": "2018-06-30",
"Value": 6144000
},
{
"Currency / Unit": "USD",
"End character": 117,
"End date for period": "2018-06-30",
"Label": "us-gaap:AccrualForEnvironmentalLossContingencies",
"Start character": 112,
"Start date for period": "2018-06-30",
"Value": 6144000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | Number of shares of the registrant’s Common Stock, $0.001 par value, outstanding on July 30, 2018: 57,992,576 | [
{
"Currency / Unit": "shares",
"End character": 109,
"End date for period": "2018-07-30",
"Label": "dei:EntityCommonStockSharesOutstanding",
"Start character": 99,
"Start date for period": "2018-07-30",
"Value": 57992576
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | As of June 30, 2018, we had cash, cash equivalents and marketable securities of $936.6 million. Although we have incurred recurring losses and expect to continue to incur losses for the foreseeable future, we expect our cash, cash equivalents and marketable securities will be sufficient to fund current operations for at least the next twelve months from the issuance date of these financial statements. | [
{
"Currency / Unit": "USD",
"End character": 86,
"End date for period": "2018-06-30",
"Label": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
"Start character": 81,
"Start date for period": "2018-06-30",
"Value": 936600000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | There have been no changes to the valuation methods during the six months ended June 30, 2018. We evaluate transfers between levels at the end of each reporting period. There were no transfers between Level 1 and Level 2 during the six months ended June 30, 2018. We have no financial assets or liabilities that were classified as Level 3 at any point during the six months ended June 30, 2018. | [
{
"Currency / Unit": "USD",
"End character": 18,
"End date for period": "2018-06-30",
"Label": "us-gaap:FairValueNetAssetLiability",
"Start character": 16,
"Start date for period": "2018-06-30",
"Value": 0
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | At June 30, 2018 and December 31, 2017, we held 246 and 240 debt securities that were in an unrealized loss position for less than one year, respectively. The aggregate fair value of debt securities in an unrealized loss position at June 30, 2018 and December 31, 2017 was $616.5 million and $439.4 million, respectively. There were no individual securities that were in a significant unrealized loss position as of June 30, 2018 and December 31, 2017. Given our intent and ability to hold such securities until recovery, and the lack of material of change in the credit risk of these investments, we do not consider these marketable securities to be other-than-temporarily impaired as of June 30, 2018 and December 31, 2017. | [
{
"Currency / Unit": "agio:security",
"End character": 51,
"End date for period": "2018-06-30",
"Label": "us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear",
"Start character": 48,
"Start date for period": "2018-06-30",
"Value": 246
},
{
"Currency / Unit": "agio:security",
"End character": 59,
"End date for period": "2017-12-31",
"Label": "us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear",
"Start character": 56,
"Start date for period": "2017-12-31",
"Value": 240
},
{
"Currency / Unit": "USD",
"End character": 279,
"End date for period": "2018-06-30",
"Label": "us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue",
"Start character": 274,
"Start date for period": "2018-06-30",
"Value": 616500000
},
{
"Currency / Unit": "USD",
"End character": 298,
"End date for period": "2017-12-31",
"Label": "us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue",
"Start character": 293,
"Start date for period": "2017-12-31",
"Value": 439400000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | In May 2016, we entered into the 2016 Agreement focused on metabolic immuno-oncology, or MIO, a developing field which aims to modulate the activity of relevant immune cells by targeting critical metabolic nodes, thereby, enhancing the immune mediated anti-tumor response. In addition to new programs identified under the 2016 Agreement, both parties also agreed that all future development and commercialization of two remaining cancer metabolism programs discovered under the 2010 Agreement, including AG-270, an inhibitor of methionine adenosyltransferase 2a, will now be governed by the 2016 Agreement. | [
{
"Currency / Unit": "agio:program",
"End character": 419,
"End date for period": "2016-05-31",
"Label": "agio:RevenueRecognitionMultipledeliverableArrangementsNumberOfProgramsDiscoveredUnderPreviousAgreementNowGovernedByCurrentAgreement",
"Start character": 416,
"Start date for period": "2016-05-31",
"Value": 2
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | During the research term of the 2016 Agreement, we plan to conduct research programs focused on discovering compounds that are active against metabolic targets in the immuno-oncology, or IO, field. The initial four-year research term will expire on May 17, 2020, and may be extended for up to two, or in specified cases, up to four additional one-year terms. | [
{
"Currency / Unit": "agio:extension",
"End character": 296,
"End date for period": "2016-05-31",
"Label": "agio:RevenueRecognitionMultipledeliverableArrangementsNumberOfExtensions",
"Start character": 293,
"Start date for period": "2016-05-01",
"Value": 2
},
{
"Currency / Unit": "agio:extension",
"End character": 331,
"End date for period": "2016-05-31",
"Label": "agio:RevenueRecognitionMultipledeliverableArrangementsNumberOfSpecialCaseExtensions",
"Start character": 327,
"Start date for period": "2016-05-01",
"Value": 4
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | At the end of the research term, Celgene may designate for continued development up to three research programs for which development candidates have yet to be nominated, which are referred to as continuation programs. We may conduct further research and preclinical and clinical development activities on any continuation program, at our expense, through the completion of an initial phase 1 dose escalation study. | [
{
"Currency / Unit": "agio:program",
"End character": 92,
"End date for period": "2016-05-31",
"Label": "agio:RevenueRecognitionMultipledeliverableArrangementsNumberOfResearchProgramsThatCanBeDesignatedForContinuedDevelopmentAfterTheResearchTerm",
"Start character": 87,
"Start date for period": "2016-05-31",
"Value": 3
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | Under each co-development and co-commercialization agreement entered into under the 2016 Agreement, the parties will split all post-option exercise worldwide development costs, subject to specified exceptions, as well as any profits from any net sales of, or commercialization losses related to, licensed products in the IO field. Celgene has the option to designate one program in the IO field as the 65/35 program, for which Celgene will be the lead party for the United States and will have a 65% profit or loss share. For programs in the IO field other than the 65/35 program, we and Celgene will alternate, on a program-by-program basis, being the lead party for the United States, with us having the right to be the lead party for the first such program, and each party will have a 50% profit or loss share. The lead party for the United States will book commercial sales of licensed products, if any, in the United States, and Celgene will book commercial sales of licensed products, if any, outside of the United States. | [
{
"Currency / Unit": "pure",
"End character": 404,
"End date for period": "2016-05-31",
"Label": "agio:ProfitLossSharePercentage",
"Start character": 402,
"Start date for period": "2016-05-01",
"Value": 0.65
},
{
"Currency / Unit": "pure",
"End character": 790,
"End date for period": "2016-05-31",
"Label": "agio:ProfitLossSharePercentage",
"Start character": 788,
"Start date for period": "2016-05-01",
"Value": 0.5
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | Under the terms of the 2016 Agreement, we received an initial upfront payment in the amount of $200.0 million. The 2016 Agreement provides specified rights to extend the research term for up to two, or in specified cases, up to four, additional years by paying a $40.0 million per-year extension fee. Celgene will pay an $8.0 million designation fee for each program that Celgene designates for further development and for each continuation program. During the three months ended March 31, 2017, we received $8.0 million from Celgene upon the designation of AG-270 as a development candidate. For each program as to which Celgene exercises its option to develop and commercialize, subject to antitrust clearance, Celgene will pay an option exercise fee of at least $30.0 million for any designated development program and at least $35.0 million for any continuation programs. In certain cases, Celgene may exercise its option to develop and commercialize two early-stage I&I programs, prior to Celgene designating the program for further development, by paying an option exercise fee of $10.0 million. | [
{
"Currency / Unit": "USD",
"End character": 101,
"End date for period": "2016-05-31",
"Label": "us-gaap:DeferredRevenueAdditions",
"Start character": 96,
"Start date for period": "2016-05-01",
"Value": 200000000
},
{
"Currency / Unit": "agio:extension",
"End character": 197,
"End date for period": "2016-05-31",
"Label": "agio:RevenueRecognitionMultipledeliverableArrangementsNumberOfExtensions",
"Start character": 194,
"Start date for period": "2016-05-01",
"Value": 2
},
{
"Currency / Unit": "agio:extension",
"End character": 232,
"End date for period": "2016-05-31",
"Label": "agio:RevenueRecognitionMultipledeliverableArrangementsNumberOfSpecialCaseExtensions",
"Start character": 228,
"Start date for period": "2016-05-01",
"Value": 4
},
{
"Currency / Unit": "USD",
"End character": 268,
"End date for period": "2016-05-31",
"Label": "agio:UpfrontPaymentAgreementExtensionFeeReceivable",
"Start character": 264,
"Start date for period": "2016-05-01",
"Value": 40000000
},
{
"Currency / Unit": "USD",
"End character": 325,
"End date for period": "2016-05-17",
"Label": "us-gaap:DeferredRevenueAdditions",
"Start character": 322,
"Start date for period": "2016-05-17",
"Value": 8000000
},
{
"Currency / Unit": "USD",
"End character": 512,
"End date for period": "2016-05-17",
"Label": "us-gaap:DeferredRevenueAdditions",
"Start character": 509,
"Start date for period": "2016-05-17",
"Value": 8000000
},
{
"Currency / Unit": "USD",
"End character": 770,
"End date for period": "2016-05-17",
"Label": "agio:OptionExerciseFeeReceivable",
"Start character": 766,
"Start date for period": "2016-05-17",
"Value": 30000000
},
{
"Currency / Unit": "USD",
"End character": 836,
"End date for period": "2016-05-17",
"Label": "agio:OptionExerciseFeeReceivableForContinuationProgram",
"Start character": 832,
"Start date for period": "2016-05-17",
"Value": 35000000
},
{
"Currency / Unit": "USD",
"End character": 1092,
"End date for period": "2016-05-17",
"Label": "agio:AdditionalOptionExerciseFeeReceivable",
"Start character": 1088,
"Start date for period": "2016-05-17",
"Value": 10000000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | In April 2015, we entered into the AG-881 Agreements. The AG-881 Agreements establish a joint worldwide collaboration focused on the development and commercialization of AG-881 products. Under the terms of the AG-881 Agreements, we received an initial upfront payment of $10.0 million in May 2015 and are eligible to receive milestone-based payments described below. The parties will split all worldwide development costs equally, subject to specified exceptions, as well as any profits from any net sales of, or commercialization losses related to, licensed AG-881 products. Either party may, at its own expense and with the other party's permission, undertake additional development activities outside of the scope of the development plan agreed upon with the other party. | [
{
"Currency / Unit": "USD",
"End character": 276,
"End date for period": "2015-05-31",
"Label": "us-gaap:DeferredRevenueAdditions",
"Start character": 272,
"Start date for period": "2015-05-01",
"Value": 10000000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | We are eligible to receive up to $70.0 million in potential milestone payments under the AG-881 Agreements. The potential milestone payments are comprised of: (i) a $15.0 million milestone payment for filing of a first new drug application, or NDA, in a major market, and (ii) up to $55.0 million in milestone payments upon achievement of specified regulatory milestone events. We may also receive royalties at tiered, low-double digit to mid-teen percentage rates on net sales if we elect not to participate in the development and commercialization of AG-881. | [
{
"Currency / Unit": "USD",
"End character": 38,
"End date for period": "2015-04-27",
"Label": "agio:RevenueRecognitionMilestoneMethodEligibleReceivable",
"Start character": 34,
"Start date for period": "2015-04-27",
"Value": 70000000
},
{
"Currency / Unit": "USD",
"End character": 170,
"End date for period": "2015-04-27",
"Label": "agio:PortionOfPotentialMilestonePaymentReceivableForFilingOfNewDrugApplication",
"Start character": 166,
"Start date for period": "2015-04-27",
"Value": 15000000
},
{
"Currency / Unit": "USD",
"End character": 288,
"End date for period": "2015-04-27",
"Label": "agio:PortionOfPotentialMilestonePaymentReceivableForSpecifiedRegulatoryMilestoneEventsProgram",
"Start character": 284,
"Start date for period": "2015-04-27",
"Value": 55000000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | During the three months ended June 30, 2018, Celgene submitted a Marketing Authorization Application, or MAA, to the European Medicines Agency, or EMA, for IDHIFA® for IDH2 mutant-positive R/R AML. As a result of the filing, we determined that a $15.0 million milestone payment for filing of a first new drug application equivalent in an ex-U.S. country is considered probable of being reached and a significant reversal of revenue would not occur in future periods. Under the remaining terms of the 2010 Agreement, we are eligible to receive up to $95.0 million in potential milestone payments for the IDHIFA® program. The potential milestone payments are comprised of: (i) up to $70.0 million in milestone payments upon achievement of specified ex-U.S. regulatory milestone events, including the aforementioned $15.0 million milestone for the MAA submission, and (ii) a $25.0 million milestone payment upon achievement of a specified ex-U.S. commercial milestone event. | [
{
"Currency / Unit": "USD",
"End character": 251,
"End date for period": "2018-06-30",
"Label": "agio:PortionOfPotentialMilestonePaymentReceivableForFilingOfNewDrugApplication",
"Start character": 247,
"Start date for period": "2018-06-30",
"Value": 15000000
},
{
"Currency / Unit": "USD",
"End character": 554,
"End date for period": "2018-06-30",
"Label": "agio:RevenueRecognitionMilestoneMethodEligibleReceivable",
"Start character": 550,
"Start date for period": "2018-06-30",
"Value": 95000000
},
{
"Currency / Unit": "USD",
"End character": 686,
"End date for period": "2018-06-30",
"Label": "agio:PortionOfPotentialMilestonePaymentReceivableForSpecifiedRegulatoryMilestoneEventsProgram",
"Start character": 682,
"Start date for period": "2018-06-30",
"Value": 70000000
},
{
"Currency / Unit": "USD",
"End character": 818,
"End date for period": "2018-06-30",
"Label": "agio:PortionOfPotentialMilestonePaymentReceivableForFilingOfNewDrugApplication",
"Start character": 814,
"Start date for period": "2018-06-30",
"Value": 15000000
},
{
"Currency / Unit": "USD",
"End character": 877,
"End date for period": "2018-06-30",
"Label": "agio:PortionOfPotentialMilestonePaymentReceivableForSpecifiedCommercialMilestoneEventProgram",
"Start character": 873,
"Start date for period": "2018-06-30",
"Value": 25000000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | During the three and six months ended June 30, 2017, we recognized $2.5 million and $5.3 million, respectively, as a reduction of research and development expenses. During the three and six months ended June 30, 2018, we did not recognize any reductions to research and development expenses. | [
{
"Currency / Unit": "USD",
"End character": 71,
"End date for period": "2017-06-30",
"Label": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
"Start character": 68,
"Start date for period": "2017-04-01",
"Value": 2500000
},
{
"Currency / Unit": "USD",
"End character": 88,
"End date for period": "2017-06-30",
"Label": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
"Start character": 85,
"Start date for period": "2017-01-01",
"Value": 5300000
}
] |
10-Q | 0001439222-18-000014 | 2018-08-02T09:02:03+00:00 | 20180630 | AGIOS PHARMACEUTICALS INC | As of June 30, 2018, the aggregate amount of the transaction price allocated to performance obligations that are partially unsatisfied was $121.8 million. | [
{
"Currency / Unit": "USD",
"End character": 145,
"End date for period": "2018-06-30",
"Label": "us-gaap:RevenueRemainingPerformanceObligation",
"Start character": 140,
"Start date for period": "2018-06-30",
"Value": 121800000
}
] |
Subsets and Splits
Transform Dates and Entities
Transforms and standardizes the filing and quarter dates, and the dates within entities, making the data more uniform and easier to analyze for temporal patterns and trends.
Top Entities by Count
Discovers the most frequently occurring entities and their associated currency units, providing insights into prominent mentions and economic contexts.
Stock Repurchase Program Data
Extracts key details about stock repurchase program authorizations, grouped by date, CIK, and filing timestamp, providing a structured look at these financial events.
Top Entity Labels Count
Counts the occurrences of each entity label in the dataset, providing insight into the distribution of labeled entities.
Formatted Financial Data Extract
The query performs some basic data cleaning and transformation, specifically converting date formats, but the results are limited and do not provide deep analytical insights or reveal meaningful patterns.